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Abstract  
 
	  	  	  
The development of next-generation, nanoscale technologies that interface biological 
systems will pave the way towards new understanding of such complex systems. Nanowires – 
one-dimensional nanoscale structures – have shown unique potential 
as an ideal physical interface to biological systems. Herein, we focus on the development of 
nanowire-based devices that can enable a wide variety of biological studies. First, we built 
upon standard nanofabrication techniques to optimize nanowire devices, resulting in perfectly 
ordered arrays of both opaque (Silicon) and transparent (Silicon dioxide) nanowires with user 
defined structural profile, densities, and overall patterns, as well as high sample consistency and 
large scale production. The high-precision and well-controlled fabrication method in conjunction 
with additional technologies laid the foundation for the generation of highly 
specialized platforms for imaging, electrochemical interrogation, and molecular biology. 	  
Next, we utilized nanowires as the fundamental structure in the development of 
integrated nanoelectronic platforms to directly interrogate the electrical activity of biological 
systems. Initially, we generated a scalable intracellular electrode platform based on vertical 
nanowires that allows for parallel electrical interfacing to multiple mammalian neurons. Our 
prototype device consisted of 16 individually addressable stimulation/recording sites, each 
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containing an array of 9 electrically active silicon nanowires. We showed that these vertical 
nanowire electrode arrays could intracellularly record and stimulate neuronal activity in 
dissociated cultures of rat cortical neurons similar to patch clamp electrodes. In addition, we used 
our intracellular electrode platform to measure multiple individual synaptic connections, which 
enables the reconstruction of the functional connectivity maps of neuronal circuits.   	  
In order to expand and improve the capability of this functional prototype device 
we designed and fabricated a new hybrid chip that combines a front-side nanowire-based 
interface for neuronal recording with backside complementary metal oxide semiconductor 
(CMOS) circuits for on-chip multiplexing, voltage control for stimulation, signal 
amplification, and signal processing. Individual chips contain 1024 stimulation/recording sites 
enabling large-scale interfacing of neuronal networks with single cell resolution. Through 
electrical and electrochemical characterization of the devices, we demonstrated their enhanced 
functionality at a massively parallel scale. In our initial cell experiments, we achieved 
intracellular stimulations and recordings of changes in the membrane potential in a variety of 
cells including: HEK293T, cardiomyocytes, and rat cortical neurons. This demonstrated the 
device capability for single-cell-resolution recording/stimulation which when extended to a large 
number of neurons in a massively parallel fashion will enable the functional mapping of a 
complex neuronal network.  
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CHAPTER 1  
 
Designing and Developing Complex, Integrated, and 
Biocompatible Platforms for Studying and Manipulating 
Biological Systems 
 
1.1 Overview 
The function of complex biological systems is an emergent property based on the 
coordinated activity of large numbers of cells. To date, one of the main open questions in 
biomedicine is how these individual cells work together to perform system-level functions.  
Although there have been numerous approaches to address this question, a complete 
understanding and explanation still remains to be discovered. For example, in the immune 
system cellular heterogeneity and cell-to-cell communication drive ensemble-level decision-
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making is poorly understood, despite extended attempts to uncover these principles. 
Furthermore, no general theory that describes how individual brain cells and complex neural 
circuits interact to give rise to brain function has been discovered. Advances in the understanding 
of such complex biological systems, including immunological systems and neuronal circuits, 
critically depends on the development of new technologies that would enable studies of the 
dynamics of individual cell activities as well as integrated communications at the network level. 
General platforms for high throughput interrogation of cells have the potential to 
transform how intra- and inter-cellular processes are studied. Nanomaterials and nanostructures 
are ideal candidates to form the basis of such technologies because of their sub-cellular 
dimensions. In particular, vertical nanowires (NWs) stand out for their ability to penetrate the 
cellular membrane in a minimally invasive fashion and hence provide a multiplexed chemical 
and electrical interface to the cell’s interior. Previous studies have demonstrated that cells 
cultured on NWs grow and divide over a period of weeks despite penetration. Reverse 
transcription polymerase chain reaction (RT-PCR) analyses of NW-penetrated human fibroblast 
cells (also obtained for HeLa S3 cells and rat hippocampal neurons) show that transcripts levels 
of common housekeeping genes are similar to cells cultured on either black silicon or standard 
multiwell plates (Fig. 1.1 b). Moreover, as shown in Fig. 1.1 d, NW-penetrated rat hippocampal 
and cortical neurons after several days in culture display typical electrophysiological signatures 
when patch-clamped, thus demonstrating the NW potential to be utilized as the building blocks 
of novel nanoscale technologies. 
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Figure 1.1 | Cells are healthy, despite nanowire penetration. (a) Cells cultured on NWs grow 
and divide over a period of weeks. SEM shows Human Fibroblasts 1 day after plating. (b) RT-
PCR analysis of NW-penetrated cells show that transcript levels of common housekeeping genes 
are similar to cells cultured on either blank silicon or multiwell plates. (c) Rat hippocampal 
neurons develop normally on top of NWs, even without the addition of adhesion layer. SEM 
shows neuron at 7 DIV. (d) After 6 days in culture, NW-penetrated rat hippocampal and cortical 
neurons display typical electrophysiological signature when patched with a glass micropipette.  
The goal of the research described in this dissertation has been to leverage advances in 
nano- and micro-technology to develop broadly applicable platforms based on nanowire 
structures for studying and manipulating complex biological systems, particularly neuronal 
networks. Chapter 2 focuses on our development of novel methods to fabricate perfectly ordered 
arrays of vertical, opaque or transparent NWs with user defined height, diameter, profile, density, 
and overall pattern. This well-controlled method enabled the fabrication of NWs with physical 
dimensions and spacing for optimal delivery to and chemical manipulation of non-adherent 
primary immune cells such as B-cells and T-cells, which cannot be effectively perturbed with 
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standard methodologies. Furthermore, the scalability and parallelism associated with these 
fabrication technologies in combination with the ability to generate compact assay spots can 
reduce reagent and cell requirements and in turn enable a series of efficient and effective high-
throughput screens (e.g., small molecule libraries, genome wide siRNAs, etc.), even with limited 
numbers of cells and scarce reagents. Besides their utilization for effective chemical 
perturbations for basic molecular biological studies (e.g., assessing the functional consequences 
of knocking down a specific gene) and medical applications (e.g., testing the efficacy of a 
pharmaceutical agent), we have shown their potential for several additional applications. In the 
next section, we briefly describe the use of nanowire arrays for (1) high-throughput intracellular 
molecular delivery integrated with super resolution imaging and (2) nanowire-nanodiamond 
integrated sensors for high-resolution measurements of electrical signals. 
Having demonstrated the utility of advanced nanofabrication methodologies to generate 
highly controllable and effective cell-interfacing platforms, we directed our efforts towards the 
development of electrically addressable NWs. Chapter 3 and Appendix A depict how this 
approach allowed us to develop vertical nanowire electrode arrays (VNEA), a step towards a 
scalable neuro-electronic interface that enables measurement and stimulation of multiple neurons 
in a massively parallel fashion. Here, we present the device preparation, including system setup 
and neuronal culture, and describe how the VNEA can be used for intracellular 
stimulation/recording of neuronal activity. We also describe the characterization of the VNE-cell 
interface and the two recording modes (Faradaic and capacitive) of this intracellular electrode 
platform. Furthermore, to illustrate the potential of the multiplexed stimulation and recording 
capabilities of the VNEA platform and its compatibility with conventional patch-clamp and 
fluorescence microscopy techniques, we used our VNEA platform to map multiple individual 
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synaptic connections onto a single postsynaptic neuron. The scalable neuro-electronic interface 
afforded by the VNEA paves the way for network-level interrogation and modification of large 
neuronal ensembles, and thus could be used to study the rules by which a neuronal circuit stores 
and processes information.  
To further expand the scale and capability of the VNEA device, we moved towards the 
development of a hybrid chip with vertical nanoelectrodes directly generated on a CMOS 
integrated circuit (IC). This work is discussed in Chapter 4; wherein detail the design, 
fabrication, electrochemical characterization, and biological experiments of our novel CMOS-
nanoelectrode array (CNEA). The CMOS architecture enables in situ simultaneous, low-noise 
monitoring of intracellular signals from each electrode with single-cell resolution, and current 
injection into individual electrodes to stimulate neurons with a broad range of spatiotemporal 
patterns. The first generation CNEA successfully achieved intracellular measurements and 
manipulations of membrane potentials in HEK293 cells, cardiomyocytes, and rat cortical 
neurons. Operating the CNEA in its multiplexed fashion for massively parallel, single-cell-
resolution recording/stimulation will (1) facilitate studies of the inner workings of the brain by 
enabling the generation of functional connectivity maps of neuronal networks and (2) make 
possible active alteration of the functional connectivity to engineer the network dynamic for 
cellular neuroprosthesis. 
 
1.2 Nanowires: a fundamental structure for integrated bio-interfacing tools 
One-dimensional nanostructures have drawn attention for their utility as building blocks 
in a wide range of applications. In particular, nanowires (NWs) have emerged as a powerful one-
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dimensional nanostructure because of their physical properties and high potential towards 
integrated devices. NWs (structures characterized by a few nanometers diameter and up to tens 
of micrometers length) have been studied and used as elements in electronics1,2, batteries3-5, 
photonics6-9, and biological interrogators/sensors10-14. Their advantageous physical properties 
include small diameter, large surface area, and high aspect ratio. Control over their geometry and 
chemical composition enables control over electrical, electronic, piezoelectric, magnetic, 
catalytic, and sensory properties. Besides their physical properties, the ability to generate NWs in 
a controlled fashion enables excellent control of their dimensions, ordered arrangement, 
geometrical confinement, and ultimately their integration into complex platforms towards novel 
devices and applications.     
Two different approaches are used to generate nanowires: (1) bottom-up chemical growth 
and (2) top-down fabrication via lithography and etching. The first approach uses additive 
nanomaterial growth methods (eg. catalyst-mediated vapor–liquid–solid (VLS)) to tune physical 
properties. Synthetically realized nanowires have been utilized as building blocks in several 
nanoscale-based systems, such as nanocircuits and nanoprocessors1,2,15-18, nanowire assemblies 
for novel solar cells19,20, and nano-bio interfaces11,21-28 (primarily based on nanowire field effect 
transistors – NWFETs). However, synthetic methods are difficult to scale, limiting applications 
in complex devices. An alternative approach is to generate vertical nanowires through top-down 
fabrication methods; thus enabling the generation of high-throughput perfectly ordered arrays of 
NWs with user defined heights, diameters, densities, and overall patterns. Due to their potential, 
a wide variety of vertical nanowire-based systems have been developed recently.  
NWs are an attractive platform to study cellular phenomena because their nanoscale 
dimensions allow for minimally invasive, high-resolution interrogation. As such, vertical Silicon 
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NWs (SiNWs) have been utilized as massively parallel micro-injectors  via their direct 
physical access to cells’ interior29-33. This platform also allows for systematic perturbation of 
immune cells, for which there did not previously exist effective delivery methods34-40, thus 
enabling a circuit-level understanding of immune cell function once the cellular response 
resulting from perturbation is measured and analyzed. In addition to their use as a highly 
effective and universal delivery platform, NWs have been used as building blocks for electronic 
interfaces that enable the interrogation of bioelectric activity, which underlay major biological 
communication and functional pathways.  
 
1.3 Studying Signaling Dynamics in Neuronal Networks  
Neuronal networks, which consist of a vast number of neurons interconnected via 
synaptic junctions, are of particular interest and one of the most complex biological systems. 
Along with forming the physiological basis of many biological organisms’ central and peripheral 
nervous systems, neuronal networks are also the basis of higher order cognitive properties. A 
central unanswered question in neuroscience is how interactions between neurons give rise to 
cognition and other high level functionality. Neuronal networks exhibit complex functionality 
starting at the level of individual neurons. For example, the complexity of the signal dynamics of 
an individual neuron is seen in action potentials and synaptic potentials, which are dynamic 
events that involve a complex interplay between the membrane voltage of a neuron and the 
opening and closing of its ion channels. Fundamentally, it is believed that cognitive processes, 
such as memory, learning, and logic, result from the coordinated activity of neuronal networks 
also depicted as bioelectrical circuits. Currently, a thorough understanding of the rules governing 
these circuits and their functional elements, the neurons, does not exist. Due to this limited 
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understanding, neurocognitive disorders such as Alzheimer’s disease, Autism, and Schizophrenia 
are particularly difficult to treat and diagnose41. Furthermore, a major obstacle to developing 
accurate descriptions of learning and memory is a lack of experimental tools capable of testing 
circuit-level theories in neuronal networks.  
Recent studies of neuronal circuits42,43 have been empowered by emerging experimental 
methods - calcium and voltage sensitive imaging44-49, genetically-encoded photoactivated ion 
channels50, and high-resolution anatomical circuit reconstructions51-55. Advances in electron and 
optical microscopy techniques have made possible to resolve the structural connectome of a 
small region of an animal’s brain down to the level of individual synaptic connections56. This 
structural information, however, does not necessarily provide insight into the network’s function. 
New methods to optically stimulate50, inhibit50, and measure44-47,57 neuronal activity have 
empowered fluorescence microscopy for interrogation of neuronal circuits42,58,59. Optical 
imaging measures activity-dependent light emissions from neurons, generated by fluorescent 
indicator proteins (voltage and calcium sensitive dyes).  However they provide only a rough 
approximation of neuronal activity due to due to slow intra-molecular kinetics and indicator 
saturation at high firing rates. While these methods have significantly expanded our 
understanding of neuronal networks, they come with significant shortcomings. 
While optical techniques are becoming an increasingly powerful and minimally invasive 
method to interrogate neuronal circuits, electrophysiology remains by far the most accurate 
method to characterize the activity of ion channels and synaptic currents60. Measuring a neuron’s 
membrane potential and its response to the activity of a pre-synaptic cell is one of the few 
methods (e.g. pathway-focused gene expression analysis) that can determine the strength of their 
synaptic connection60-62 (a crucial dynamic quantity long believed to be the basis of learning and 
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memory). Because whole-cell patch clamp techniques (intracellular electrical recording using a 
glass micropipette) are the only reliable way to measure and control the cellular membrane 
potential, they have remained the principle tool in neurobiology for more than 20 years63. The 
general principles of whole-cell patch clamping are summarized in Figure 1.2.  
 
Figure 1.2 | Whole cell patch clamp. (a) Optical micrograph of cultured rat hippocampal 
neurons and a micropipette interfacing a single neuron in whole-cell mode. (b) Schematic of the 
general principle of patch-clamp recordings: a glass pipette containing intracellular solution 
tightly sealed onto the cell membrane and thus isolates a membrane patch electrically. Patch 
clamping can be run in two modes; (i) Voltage clamp mode: a current is injected into the cell via 
a negative feedback loop to compensate changes in membrane potential. (ii) Current clamp 
mode: changes in the membrane potential are tracked by monitoring the patch pipette potential 
required to maintain a specified command current. 
 
While patch clamp techniques are effective when studying two to three cells at a time for 
periods up to a few hours60, they are not scalable to a large network of cells, and long-term 
recording is an outstanding challenge. New techniques are required to test many theories for 
learning and memory behavior. Efforts to parallelize this technique via planar patch-clamp chips 
have not yet been optimized for mammalian neurons, primarily because of difficulties in forming 
seals to their small neuronal cell bodies64-68. For large-scale interrogation of neuronal networks, 
microelectrode arrays (MEAs) are the tool of choice because they can monitor the neuronal 
activity from many neurons simultaneously. MEAs measure neuronal signals by detecting the 
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changes in the extracellular field resulting from the current flows from ionic processes across 
closest and nearby neurons69. A variety of MEAs based on Pt electrodes64, top-gated70 and 
nanowire transistors13,71-73, etc. have improved the number of neurons which can be measured 
simultaneously. However, since these measurements are extracellular, they do not provide a clear 
signal-to-cell registry or information about individual synapses. As a result of these experimental 
limitations, the principles of neuronal coding – the rules by which neuronal circuits store and 
processes information – remain among the brain’s least understood functionalities74.  
To address some of these issues and pave the way for large-scale neuronal network 
studies, semiconductor nanofabrication-based approaches have been employed to generate a new 
class of electrical interfaces to neurons and other electroactive cells. These tools, reviewed in 
detail elsewhere, rely on nano- and microscale structures that provide a minimally invasive 
interface to the cell’s interior. For example, gold mushroom-shaped microelectrodes can perform 
multisite ‘intracellular-like’ recording and stimulation of neuronal activity in Aplysia neurons 
and primary rat cardiomyocytes75-77. Similarly, nanoscale structures based on field-effect 
transistors (FET) or vertical platinum nanowires enable true intracellular recording of action 
potentials in cardiomyocytes10,11,72,73. Each of these methods utilizes nanofabrication approaches 
to create recording platforms that can be scaled up to interrogate many cells simultaneously 
without using micromanipulators. A logical next step, then, is a nanofabricated device 
specifically designed and optimized to stimulate and record the activities of primary mammalian 
neurons. 
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CHAPTER 2  
 
Generation of Biomolecular Perturbation and Imaging 
Platforms through High-Throughput, High-Precision 
Nanowire Fabrication Methods  
 
2.1 Introduction: Vertical and opaque silicon nanowires 
Controlled and specific biomolecular perturbations comprise the basis of the majority of studies 
that aim to elucidate cellular function78-83. A generalized platform for high throughput interrogation and 
manipulation of living cells could transform investigations of intra- and inter-cellular processes. Vertical 
silicon nanowires (SiNWs) are a promising foundation for such technology. They are capable of 
penetrating a cell’s membrane in a minimally invasive fashion, providing a multiplexed chemical and 
electrical interface to the cell’s interior84-88.  
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Studies in our lab established surface-modified SiNWs as a spatially localized, efficient, and 
universal biomolecular delivery platform89. Surface modification, particularly aminosilane coating of the 
SiNWs, facilitated noncovalent (electrostatic and/or van der Waals), nonspecific binding of a variety of 
biomolecules. Cells were subsequently plated on the coated SiNWs and incubated to allow for 
intracellular nanowire penetration and slow release of the biomolecules. Figure 2.1 summarizes the 
operational principle of this SiNW perturbation platform.  
 
 
Figure 2.1 | SiNWs: A generalized platform for delivering a large variety of biological effectors. (a) 
and (b) Scanning electron micrographs of vertical SiNWs fabricated via CVD and reactive ion etching, 
respectively. Scale bar in (a) and (b), 1 µm.	  (c) and (d) Schematic renderings of cells (pink) on SiNWs 
(green) at early and late stages of penetration, respectively. Molecules of interest (X & Y) are non-
specifically tethered to the SiNW surface via alkoxysilane treatment. Upon penetration and delivery, 
those molecules can alter the cell’s behavior. (e) and (f) Confocal microscope sections (corresponding to 
the dashed boxes in c and d) of a HeLa cell in the process  of being penetrated. Scale bar in E and F, 10 
µm. (e) After 15 minutes, the cell  membrane, labeled with DiD, sits atop the tips of the wires that are 
coated with cystamine and Alexa Fluor 488 SE (as shown in c). (f) Within one hour, the same plane 
shows a red circle, the cell's circumference, surrounding green-labeled wires, indicating NW penetration 
into the cell (as shown in d). Regardless of the molecular coating, the majority of cells are penetrated 
within one hour. 
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Direct access to the cells’ interiors enables NWs to efficiently deliver a broad range of exogenous 
materials into multiple cell types, without the need for chemical or viral packaging protocols required by 
other methods. Fluorescence images in Fig 2a to d show immortalized (HeLa) and primary cells (human 
fibroblasts, rat neural progenitor cells (NPCs), and rat hippocampal neurons) expressing fluorescent 
proteins encoded by plasmid DNAs that were administered using SiNWs, whereas Fig. 2.2e to h 
demonstrates the delivery of various biomolecule, (siRNAs, peptides, DNAs, and proteins). Moreover, 
different types of biomolecules can be introduced into the same cell simultaneously by simply 
codepositing them onto the NWs, as illustrated in Fig. 2.2i to l. The fluorescence images in Fig. 2.2e to l 
were obtained by culturing human fibroblasts on Si NWs to which diverse fluorescently labeled 
molecules were attached. Because the vertical NW platform is compatible with live-cell cultures and 
common imaging protocols, phenotypic responses to exogenous biological effectors can be assayed 
directly using standard microscopy techniques. 
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Figure 2.2 | Si NWs can deliver and codeliver diverse biomolecular species to a broad range of cell 
types. (a)-(b) Various immortalized and primary cell types expressing fluorescent proteins after being 
transfected with plasmid DNA via the Si NWs: (a) HeLa S3 cells (pCMV-TurboRFP), (b) human 
fibroblasts (pCMVTurboRFP), (c) NPCs (pCMV-mCherry), and (d) primary rat hippocampal neurons 
(pCMV-dTomato). Scale bar in a-a, 25 µm. (e)-(h) Human fibroblasts transfected with a variety of 
biochemicals. To verify intracellular delivery, following a 24-h incubation on coated Si NWs, cells were 
replated on glass coverslips for imaging. Epifluorescence images show >95% of the cells receive: (e) 
siRNA (Alexa Fluor 546 labeled AllStar Negative Control siRNA), (f) peptides (rhodamine labeled 9-
mer), (G) plasmid DNA (labeled with Label-IT Cy5), and (h) proteins (recombinant TurboRFP-mito). 
Scale bars in e-h, 50 µm. (i)-(l) Fluorescence images of human fibroblasts cotransfected with two 
different molecules using Si NWs: (i) two different siRNAs (Alexa 546 labeled siRNA-yellow & Alexa 
647 labeled siRNA-magenta), (j) a peptide and an siRNA (rhodamine labeled peptide-yellow & Alexa 
647 labeled siRNA-magenta), (k) plasmid DNA and an siRNA (Cy5-labeled TagBFP plasmid DNAyel-
low & Alexa 546 labeled siRNA-magenta), and (l) a recombinant protein and an siRNA (recombinant 
TurboRFP-mito-yellow & Alexa 647 labeled siRNA-magenta). In e to l, to facilitate identification, cell 
membranes were labeled with fluorescein (Gray). Scale bars in i–l, 25 µm. 
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2.2 SiNW Fabrication Method 
To further expand the applicability and utility of the SiNW platform, we developed a novel 
method to fabricate perfectly ordered SiNW arrays with user defined heights, diameters, densities, and 
overall patterns. Further implementation and integration of this method enables massively parallel high-
throughput screening. Principally, our method utilizes a top down fabrication approach that integrates a 
wide variety of well-understood semiconductor processes. In brief the fabrication process consists of the 
following steps, as shown in Fig. 2.1: (1) A silicon wafer is coated with a thin resist. (2) That resist is 
patterned using lithography (stepper photo-lithography) and development to define a series of resist holes 
at specified locations – these holes mark the location of the SiNWs to be fabricated. (3) A hard etch mask 
(preferably aluminum oxide for maintaining CMOS compatibility) is deposited and the resist is lifted off 
to leave hard etch mask spots at the sites of SiNWs-to-be. (4) The exposed silicon is etched to the desired 
depth using a reactive ion etch (RIE), yielding SiNWs pillars of the specified height at the protected sites. 
Our standard process RIE was performed for 25 minutes using the STS ICP RIE at 1200RF power, while 
flowing in 160sccm C4F8 and 60sccm SF6 gas, which leads to selective etching of the silicon substrate 
underneath.  (5) The hard etch mask is removed. (6) At this point, the SiNWs can be used as previously 
described90 or their diameters can be adjusted down by oxidation (preferably, thermally) and subsequently 
etching away the formed oxide (RIE or a wet etchant, e.g. HF). This process can be cycled as needed. 
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Figure 2.3 | Summarized process-flow of patterned SiNW fabrication: 1 – A thin resist is patterned; 2 – 
The inverse of the pattern is generated by depositing a hard mask and lifting off; 3 – Exposed silicon is 
etched down to leave SiNWs; 4 – The etch mask is removed; and, 5 – If desired the SiNWs are thinned 
down using cycles of oxidation and selective oxide etching. 
 
The development of this optimized top-down fabrication process enabled the scalable production 
of SiNWs with complete tunable geometry (length, density, diameter). In particular, using stepper 
photolithography for the definition of this array allows for precise control of the pitch between NWs and 
by extension the amount of nanowires that will engage a typical cell cultured on top of them. For smaller 
suspension cells like B and T-cells, the density is about 0.65 NW per µm2, which corresponds to an array 
with a 1.25µm pitch. The height of the NWs emerging underneath the mask is controlled accurately by 
the RIE step. In addition, the final diameter of the nanowires can be controlled within a few tens of 
nanometers by repeated oxidation and oxide removal (Fig 4 c,d). Control over the NW profile, using 
different thin-down strategies, enables the fine-tuning of NW geometry thus in the generation of the 
optimal interface with cells of different characterizing features. In particular, the sharpness of the NW tip 
(e.g. Fig 4f) turns out to be of crucial importance for delivery of biomolecules to suspension cells that, 
compared to adherent cells, adhere less strongly to the culture substrate. 
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Figure 2.4 | SiNWs can be fabricated with consistent geometries at a specified density over a large area. 
(c – d) The diameter of the patterned SiNWs can be controlled by repeated oxidation and oxide removal. 
Different thinning strategies can be used to define SiNW shape and profile, (e) conformal and (f) 
directional. 
 
 
2.3 Biomolecular perturbation using SiNWs 
 
The SiNW platform has been applied to address fundamental problems in immunology through 
several collaborations91-95. By using the NWs to deliver perturbants into primary immune cells, we have 
interrogated the intracellular circuits that drive cellular functions in both normal and diseased states. As 
previously described, NW surface termination facilitates the conjunction of biomolecules92,94. A short 
aminosilane was used to bind siRNA to the nanowire surface in a non-covalent manner. This charge 
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based, non-specific binding method opens up the possibility to employ the NW platform to co-deliver 
different types of biomolecules (mRNA, plasmids, negatively charged proteins, etc.). Subsequently, the 
siRNA coated NWs are used as a culture substrate and merely by gravitational forces cells will settle onto 
the vertical nanowires, allowing siRNA release to the cytoplasm over time. Analysis by confocal 
microscopy of human B-cells (cell membrane colored magenta) from CLL patients cultured on top of a 
NW substrate (colored white), suggests that NWs reside in the cytoplasm (Figure 2.3.2a). In addition, 
being cultured on top of a NW substrate did not alter cell health or morphology greatly (Figure 2.3.2b). 
Importantly, NW-mediated delivery neither activated an immune response nor interfered with normal 
immune sensing, cellular activation, or cell proliferation in response to physiological signals.  
 
 
Figure 2.5 | Nanowires can deliver siRNA into ex vivo primary immune cells. (a) Three dimensional 
reconstruction (left) of confocally imaged human B cells (membrane: magenta) on top of Alexa-labeled 
NWs (white). (b) Scanning electron microscope images of CLL-B cells on top of NWs taken 24 h after 
plating. 
 
The NW substrates were successfully used to introduce a variety of molecular cargo into immune 
cells; in particular, to investigate the molecular circuits that guide naïve mouse CD4+ T-cell 
differentiation 96. Imbalance in the population of T-cell subtypes can lead to various autoimmune diseases 
because proper immune system function requires a balanced population and their proper activation 97,98. 
Consequently, identifying the relevant molecules and pathways that control naïve T-cell differentiation is 
not only a basic scientific problem, but also one with substantial clinical relevance. To address this, we 
combined transcriptional profiling at high temporal resolution, novel computational algorithms, and 
	  19	  
	  
innovative nanowire-based tools for performing perturbations in primary T-cells to systematically derive 
and experimentally validate a model of the dynamic regulatory network that controls Th17 differentiation 
(Fig. 2.6). By profiling gene expression during Th17 differentiation, we identified genes that were 
differentially expressed with respect to controls that lacked Th17 inducing cytokines (TGF-B & IL-6). 
Using this time-course data, we reconstructed a dynamic regulatory network model for Th17 
differentiation consisting of three distinct temporal phases.  
In order to experimentally validate this model and infer directionality of regulation, we needed to 
perturb key Th17 differentiation genes; yet, traditional perturbation methods, like viral- or transfection-
based siRNA delivery, have been of limited utility since they either alter differentiation or cell viability in 
unstimulated primary mouse T-cells 99,100. By leveraging NW-based siRNA delivery, we were able to get 
around this hurdle and successfully knockdown 39 regulators in the Th17 network. Figure 2.6c shows 
scanning electron micrograph of primary T-cells (false colored purple) cultured on vertical silicon 
nanowires. This perturbation data allowed us to identify that the network is organized into two 
antagonistic modules: a module of 22 ‘Th17 positive factors’, whose perturbation decreased the 
expression of Th17 signature genes, and a module of 5 ‘Th17 negative factors’, whose perturbation did 
the opposite. The two antagonistic modules may play a key role in maintaining the balance between Th17 
and other T-cell subsets and in self-limiting the pro-inflammatory status of Th17 cells. To further analyze 
the role of key novel genes, the validated model was tested by differentiation of naïve T-cells from 
knockout mice of the novel factors. Intracellular staining followed by flow cytometry and cytokine 
analysis (ELISA) of the corresponding supernatants confirmed the predictions by our model. Overall, this 
study identified and validated 39 regulatory factors, embedding them within a comprehensive temporal 
network and revealing its organizational principles, and highlighted novel drug targets for controlling 
Th17 differentiation96. 
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Figure 2.6 | (a) Overview of approach. (b) Gene expression profiles during Th17 differentiation. Shown 
are the differential expression levels for genes (rows) at 18 time points (columns) in Th17 polarizing 
conditions (TGF-β1 and IL-6; left panel, Z-normalized per row) or Th17 polarizing conditions relative to 
control activated Th0 cells (right panel, log2(ratio)). The genes are partitioned into 20 clusters (C1-C20, 
color bars, right). (c) Scanning electron micrograph of primary T cells (false colored purple) cultured on 
vertical silicon nanowires. (c) Effective knockdown by siRNA delivered on nanowires. Shown is the % of 
mRNA remaining after knockdown (by qPCR, Y axis: mean ± standard error relative to non-targeting 
siRNA control, n = 12, black bar on left) at 48hrs after introduction of polarizing cytokines. (d) Two 
coupled and opposing modules. Shown is the perturbation network associating the ‘positive regulators’ 
(blue nodes) of Th17 signature genes, the ‘negative regulators’ (red nodes), Th17 signature genes (grey 
nodes, bottom) and signature genes of other CD4+ T cells (grey nodes, top). A blue edge from node A to 
B indicates that knockdown of A downregulates B; a red edge indicates that knockdown of A upregulates 
B. Light grey halos: novel regulators. (e) Example network model of key targets and regulators (round 
nodes) connected to the pivotal nodes based on perturbation (red and blue dashed edges), TF binding 
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Figure 2.6 (Continued). (black solid edges), or both (red and blue solid edges). Intracellular staining and 
cytokine assays by ELISA or Cytometric Bead Assays (CBA) on culture supernatants at 72h of in vitro 
differentiated cells from the respective KO mice. 
 
 
 
2.4 Future directions of SiNW-based platforms 
In future efforts, we will enhance the scale at which NW-based perturbations can be performed to 
accommodate large-scale perturbation studies towards the facilitation of conducting a genome-scale 
screen of regulators in primary immune cells (~500-1,000 genes). For this purpose, by selectively 
protecting regions of the silicon wafer, regions without SiNWs can be generated.  This enables the 
delineation of active delivery (SiNW-containing) regions and non-delivery zones (Fig 7). By attaching a 
well structure, made of patterned silicon, PDMS, or any other polymer, these active zones can be isolated 
from one another to generate SiNW transfection wells. Subsequently, different molecular reagents can be 
deposited within these wells (by pipetting, micro arraying, or the like) and then, by adding cells to the 
entire structure, the consequences of delivering different molecules, either alone or in combination, can be 
assayed in parallel in high throughput. Different cells can be spotted onto different areas to enable a 
screen of fewer molecules across multiple cell types. Similarly, the washers that define the assay wells 
can be affixed to the surface without pre-defining SiNW free binding regions by using photoresist to 
protect certain areas and then adding a curable polymer; similarly, wells can be defined by photo-
lithographically patterning boundaries in a photo-curable polymer or resist (e.g., spin on glass) and the 
developing. 
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Figure 2.7 | By selectively protecting regions of the silicon surface, spots of SiNWs can be made.  Once 
these transfection-competent regions are defined, they can be isolated through the addition of a washer 
structure (e.g., PDMS).  Coupled with selective dispensing, this enables the functional consequences of a 
wide variety of different molecules (e.g., drug candidates, siRNAs) to be assayed, either alone or in 
combination, in parallel using a small area and a small number of cells, thus enabling truly high 
throughput screens. 
 
We envision that this strategy will enable a series of efficient and effective high-throughput 
screens (e.g., small molecule libraries, genome wide siRNAs, etc.), even with limited numbers of cells 
and scarce reagents.  If wells of 175 um by 175 um are generated at 200 um pitch, 25 would fit in a square 
mm, and more than 400,000 wells would fit onto a standard 6 inch silicon wafer (1.6 million on a 12 
inch).  This means that over 400,000 (1.6 M) different molecules (of the same or different specifies) or 
combinations thereof could be screened simultaneously using one SiNW wafer.  The compact assay spot 
would reduce reagent and cell requirements. Also, the full wafer can be trimmed to any shape with a 
dicing saw to enable compatibility with different high-throughput screening platforms (e.g., optical 
microscopes). Finally, in order to accommodate large-scale perturbation studies, efforts could be taken to 
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automate the protocol. By coupling the nanowire platform to robotics, a high throughput process line, 
including fluorescence based phenotype readout, can be established that enables quick screening, and 
expand the combinatorial combinations that can be probed. 
 
 
2.5 Generating transparent SiO2 NW based platforms 
 
Vertical Si NWs have been broadly utilized as a scalable and highly effective platform to obtain 
intracellular access to living cells for both perturbing and observing their cellular phenomena. To further 
expand the functionality of vertical nanowires, we moved into the development of a similar biological 
interface with the distinct feature of transparency in comparison to the opaqueness of Si NWs. The 
advanced transparent nanowire arrays are realized by employing optimized Si NW fabrication techniques 
on top of quartz wafers. These transparent structures pave the way towards truly multiplexed platforms 
that can be directly integrated with microscopy systems paving the way towards novel applications 
including: (1) the visualization of the nanowire/cellular-membrane interface through stochastic optical 
reconstruction microscopy (STORM) and (2) the development of a new sensing platform that consists of 
nanodiamonds (NDs) selectively tethered at the nanowire tips. 
 
2.6 Fabrication Summary 
Transparent NW substrates are prepared in via a top-down approach by etching them from silicon 
dioxide (SiO2; quartz and/or fused silica) wafers using standard semiconductor techniques (stepper 
lithography, directional reactive ion etching, and isotropic wet etching) tailored for this application. 
Varying the processing parameters can precisely control the structural profile and layout of the SiO2 NWs 
(Fig. 2.8b), in similar fashion with the opaque Si NWs as described above. To achieve the critical 
parameter of feature uniformity within the die and across the wafer, we implemented two additional steps. 
First, we corrected for pattern non-uniformity that resulted from optical reflection due to the transparent 
substrate by depositing a reflective film (Copper) in the bottom of the wafer. This prevents any reflection 
	  24	  
	  
from the wafer holding chuck, thus improving exposure uniformity. In addition, an anti-reflective coat 
(ARC) layer on the top of the wafer was used to reduce unwanted optical effects from backscattering and 
reflection through the photoresist. The process described above is performed on 4-inch wafers (Fig. 2.8a), 
which can be subsequently diced up and/or post-processed for particular applications.  
 
 
Figure 2.8 | Fabrication of transparent nanowires from quartz wafers 
 
 
 
2.7 STORM Experiment 
 
The distinct feature of transparency enables these NW based platforms to be implemented with 
STORM for superresolution imaging101 based on the high-accuracy localization of individual 
fluorophores. As shown in Fig. 2.9a, bare SiO2 NWs labeled with Alexa-647 fluorophore were imaged in 
index-matched media by maximizing the possible localizations to define their overall structure over a 
1µm length (z-dimension). To visualize the interface between the NWs and the cellular membrane of 
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primary cells we cultured bone-marrow-derived dendritic cells (BMDCs) on top of labeled SiO2 NWs. 
Pre-imaging sample preparation consisted of two steps: (1) fixating the cultured cells with 
paraformaldehyde combined with glutaraldehyde and (2) labeling the cellular membrane with CM-Dil. 
The distinct and separated emission spectra of Alexa-647 and CM-Dil allowed for multicolor STORM 
imaging using a multichannel fluorescence detection scheme. Figure 2.9b, bottom shows the x-z 
projection of the NW-membrane interface of the boxed region shown in Fig. 2.9b, top, indicating the 
cellular penetration of SiO2 NWs. A similar multicolor approach can be used to achieve superresolution 
imaging of live cellular cultures, which are being perturbed via the NWs. Integrating the capability of 
SiO2 NW intracellular perturbation with superresolution imaging, through their transparent substrate, will 
facilitate truly multiplexed studies of complex biological systems paving the way towards new insights at 
the nanoscale. 
 
Figure 2.9 | Visualization of the NW/cellular-membrane interface through STORM.  
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2.8 Nanowire - Nanodiamond Integration  
 
Another aptitude of the transparent SiO2 NWs as an interfacing substrate is the possibility to 
develop a new sensing platform that consists of nanodiamonds (NDs) selectively tethered at their tips. As 
discussed below, NDs enable the measurement of voltage changes by leveraging the nanoscale magnetic 
and electric sensing properties of nitrogen-vacancy centers in NDs102-105. Their integration with SiO2 NWs 
ensures optimal placement of the NDs in close proximity to the plasma membrane for achieving high 
sensitivity and enables detection of the voltage pulses through the transparent substrate. This platform 
will enable minimally invasive interrogation of neuronal networks with high-spatial resolution. 
 Nitrogen vacancy (NV) centers in nanodiamonds are distinguished by superior optical properties 
and are paving the way for the development of novel applications such as bright biomarkers, switch-
controlled emitters for high-resolution microscopy, and optical sensors for electrochemical detection. 
Their capability as nanoscale optical sensors and probes has shown great potential for biological sensing 
applications, in particular for measuring the membrane potential. Recent developments in optical voltage 
sensors, including voltage-sensitive dyes and genetically coded proteins, are limited due to their 
properties of intracellular delivery, potential toxicity, and typical photo bleaching. The NV centers in 
nanodiamonds, with their photoluminescence sensitivity to perturbations in electric fields and chemical 
changes, provide a non-invasive technique for highly sensitive detection of electrochemical activity with 
remarkable biocompatibility.  
To avoid shortcomings associated with the direct field-sensing106 method (including imperfect 
spin readout of a single NV center and the Debye screening of the membrane potential), we have 
implemented NV center charge state readout as an indirect electric-field detector. The NV center can exist 
in two charge states, NV- and NV0, which are associated with distinct excitation and fluorescence spectra 
that enable fast (less than 15µs) and efficient (fidelity > 90%) readout of the charge state107,108. The 
equilibrium state of an NV can shift between NV- and NV0 (directly leading to the fluorescence spectra 
change) when the NV center is subject to an external electric field. In this way, the detection of the 
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spectra shift, through spectral filtering of fluorescence photons, enables the measurement of electric 
fields. Figure 2.10 depicts the results of our proof-of-concept experiment demonstrating the detection of 
voltage pulses through the detected fluorescence signals. We simulated a cellular-like measurement setup, 
schematically shown in Fig. 2.10a, consisting of the detector platform (nanodiamonds deposited on a 
glass slide coated with a conductive indium-tin-oxide (ITO) film), the extracellular solution, and an 
electrode immersed in the extracellular solution. We utilized the immersed electrode as the source of 
voltage pulses to simulate changes in cellular membrane potential. The preliminary results, Fig. 2.10c, 
demonstrate the detection of increasing amplitude voltage pulses (0 to 500 mV) characterized by 1 ms 
duration, thus showing the feasibility of this new voltage-sensing modality through the measurements of 
the fluorescence signal.  
 
 
Figure 2.10 | (a) The nanodiamonds, drop-cast on a glass slide with a conductive indium-tin-oxide (ITO) 
coating. (b) The voltage pulses that simulated membrane potential changes were applied to an electrode 
that was held inside extracellular solution, which was in contact with the surface. (c) Detected 
fluorescence signals, showing detection of the voltage pulses, for pulse amplitudes between 0 and 500 
mV. 
 
Having shown this novel voltage-sensing modality, we moved towards the integration of the 
nanodiamond sensors with the SiO2 NW substrate to further expand and optimize the platforms’ potential. 
This combined platform was achieved via a multiple step process-flow, Fig. 2.11a, which allowed the 
generation of a conductive surface in addition to the conjunction of NDs in a selective methodology. 
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Briefly, these step consisted of: (1) conformal deposition of a conductive indium-tin-oxide (ITO) via 
sputtering, (2) surface functionalization with aminosilane, (3) selective tip exposure through a height 
controlled resist layer to shield the base, (4) ND covalent attachment via drop-casting a solution with 
activated NDs, and (5) resist removal and sample clear-out. Figure 2.11b shows SEM images of the final 
results of our ND-NW platform preparation, demonstrating our control over the localization of the NDs 
on the NWs. To evaluate the properties of the post-processed NDs attached to NWs and the 
characteristics of the transparent substrate, we utilized the pulsed electron spin resonance (ESR) 
technique. The fluorescence detection in the x-y plane, shown in Fig 2.11d, depicts a good uniformity of 
the ND distribution across the NW array. Furthermore, the ESR spectra (NV population in ms=0 vs. 
microwave (MW) frequency) show the typical MW frequency that is resonant with the ms=0 to ms=1 spin 
transition, Fig. 2.11e. The ability to achieve optical detection through the NW substrate demonstrates the 
possibility of generating the ND-NW integrated platform with great potential.    
 
 
Figure 2.11 | Nanodiamonds integrated with transparent NWs. (a) Process flow to selectively attach 
NDs to the SiO2 NWs. (b) SEM images of NDs tethered to the upper portion of the vertical NWs to 
achieve high SNR. (c) Schematic of the sensing platform interfacing a single cell. (d-e) ESR on NDs 
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Figure 2.11 (Continued). attached to SiO2 array. 
 
2.9 Conclusions and prospects 
 
The development of these integrated and transparent, NW-based platforms gives rise to novel 
nanoscale based interrogative techniques for biological systems. Building upon the current results, we 
will utilize the ND-NW platform to investigate neuronal networks through measurements of their 
membrane potential. Besides the ability of the NV detection system to acquire the membrane potential 
activity in a non-invasive fashion with high spatial resolution, the integrated platform facilitates the well-
controlled and optimized localization of ND sensors to achieve high signal-to-noise ratio. While, 
monitoring the membrane potential in multiple points of a single neuron can be used to map intracellular 
dynamics of neuronal activity, large-scale interrogation at the network level will facilitate the 
determination of the combined functional and structural connectivity.  
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CHAPTER 3 
 
Vertical Nanowire Electrode Arrays as a Scalable 
Platform for Intracellular Interfacing to Neuronal Circuits 
 
3.1 Introduction 
Deciphering the neuronal code - the rules by which neuronal circuits store and process 
information - is a major scientific challenge42,74. Currently, these efforts are impeded by a lack of 
experimental tools that are sensitive enough to quantify the strength of individual synaptic 
connections and also scalable enough to simultaneously measure and control a large number of 
mammalian neurons with single-cell resolution60,64. Here, we report a scalable intracellular 
electrode platform based on vertical nanowires that affords parallel electrical interfacing to 
multiple mammalian neurons. Specifically, we show that our vertical nanowire electrode arrays 
(VNEAs) can intracellularly record and stimulate neuronal activity in dissociated cultures of rat 
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cortical neurons and can also be used to map multiple individual synaptic connections. The 
scalability of this platform, combined with its compatibility with silicon nanofabrication 
techniques, provides a clear path toward simultaneous, high-fidelity interfacing with hundreds of 
individual neurons. 
To date, most microfabricated neuronal interfaces have been based on electrodes that 
reside outside of the cellular membrane, preventing their use for measuring sub-threshold events 
and also prohibiting precise cell-to-electrode registration64,65,71,109-113. Recently, emerging 
nanofabrication techniques have enabled the development of new micro- and nanoscale devices 
that exhibit significantly improved electrical coupling between cells and electrodes. Notably, 
gold mushroom-shaped microelectrodes have been used to perform “intracellular-like” 
recordings from Aplysia neurons and mammalian cell lines75,76,114, and true intracellular 
recordings from several mammalian cell lines and cardiomyocytes have been realized using 
microfabricated planar patch clamp devices66-68 and kinked nanowire probes11. Although these 
examples represent major advances in cell-electrode coupling, they have been either too large to 
interface to mammalian neurons66-68,75,76, or lack the scalability required to perform simultaneous 
measurements of multiple cells11. 
  
3.2 Device Design and Fabrication 
Our VNEA is specifically designed to address these issues by leveraging the same 
nanofabrication technology that enables mass production of integrated silicon electronic circuits. 
Vertical nanowire electrode arrays (VNEAs) were fabricated on a silicon-on-insulator (SOI) 
wafer with a degenerately doped device layer (Ultrasil Corp., n- and p-type, 0.001 – 0.005 
Ohm cm), as depicted in Fig. 3.1. Our prototype VNEA device consisted of 16 
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stimulation/recording pads (200 µm pitch), each containing 9 vertical silicon nanowires (3 × 3, 
2-µm pitch, Figs. 2A-C). Silicon nanowires (~ 150 nm in diameter and 3 µm in length) were 
fabricated via reactive ion etching (RIE) and thermal oxide thinning. Briefly, 600-nm diameter 
holes in poly(methyl methacrylate) were patterned via electron-beam lithography. Subsequent 
evaporation and liftoff yielded 30-nm thick alumina discs that served as an etch mask. Reactive 
ion etching of the surrounding silicon surface produced 3-µm tall silicon nanowires that were 
then thinned down via thermal oxidation and wet chemical etching. The silicon surface was next 
passivated with thermally grown SiO2 (20 ~ 40 nm in thickness). Selective metallization of the 
nanowire tips was achieved by spinning a thin layer of photoresist (500 nm, Shipley 1805) so as 
to leave the nanowires’ tips exposed. After the tips’ oxide layer was stripped with buffered HF, 
the exposed silicon was metalized with 10 nm of Ti followed by 50 nm of Au via sputtering and 
liftoff. To improve contact resistance, the VNEAs were annealed at 250oC in nitrogen. 
Subsequently, stimulation/recording pads were made independently addressable by first defining 
electrode tracks using photolithography and then etching away the interstitial regions via RIE. 
These tracks were then passivated via atomic layer deposition of a 100-nm layer of Al2O3. The 
Al2O3 layer covering the nanowires was removed via photolithography and selective wet 
chemical etching (TransEtch-N, Transene). Finally, a metal contact pad (50 nm Ti/50 nm Au) 
was added to each electrode track to facilitate electrical interfacing to our measurement setup. 
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Figure 3.1 | VNEA device fabrication. (a) Image of a set of 9 completed VNEA devices, 
fabricated in parallel on a 4-inch SOI wafer. (b) Image of a representative VNEA device 
consisting of 16 stimulation/recording pads and a polydimethylsiloxane (PDMS) washer with 
three cell-culture wells: a central double well that surrounds the active region of the device and 
two additional wells that hold neurons for media conditioning. (c) Device fabrication process 
flow. Briefly, from left to right, then top to bottom: devices were fabricated on an SOI wafer 
with degenerately doped silicon device and handle layers (cyan) and a 2 – 4 µm thick buried 
oxide layer (gray). Electron-beam lithography, followed by aluminum evaporation and liftoff, 
yielded 600-nm diameter aluminum discs (blue) at positions intended for nanowire fabrication. 
The aluminum discs served as a hard mask for RIE, yielding arrays of silicon nanowires. The 
nanowires were then thinned down via thermal oxidation and wet chemical etching to obtain 
diameters of 150 nm. Next, SiO2 (gray, 20 - 40 nm in thickness) was grown thermally, and a thin 
layer of photoresist (red) was spun on top, leaving the nanowire tips exposed. Oxygen plasma 
cleaning and buffered oxide etch were used to remove the SiO2 covering the nanowire tips. 
Immediately following oxide removal, the sample was sputter-coated with metal (yellow). 
Subsequent liftoff yielded metal caps only at the nanowire tips. Next, photoresist was patterned 
to define the electrode tracks used to address the nanowires, and the interstitial silicon was 
etched away using RIE. The entire device was then insulated using an Al2O3 layer (blue). The 
Al2O3 layer covering the nanowires was then removed using selective wet chemical etching 
followed by removal of the photoresist.  
 
Figure 3.2 shows a prototype VNEA with 16 stimulation/recording pads. The entire 
device was fabricated from a silicon-on-insulator (SOI) substrate so that each pad could be 
independently addressed electrically. At the center of each stimulation/recording pad lies a 3 × 3 
array of 9 silicon nanowires (~150 nm in diameter, 3 µm in length, at a 2-µm pitch). Each 
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nanowire in the array consists of a degenerately doped silicon core encapsulated by a silicon 
dioxide (glass) shell, and is capped with a sputter-deposited metal tip (Ti/Au: see Fig. 3.2a): the 
silicon core and metal tip provide electrical access to the cell’s interior, whereas the glass shell 
plays the dual role of preventing current leakage through the nanowire sidewalls and serving as a 
material for making tight seals to the cell membrane60. The geometry of each nanowire array (a 
4-µm square) was chosen to be smaller than the size of a typical neuronal cell body so as to 
increase the probability of single-neuron coupling. 
 
Figure 3.2 | Vertical nanowire electrode array (VNEA) for interrogating neuronal 
networks. a, Scanning electron microscope (SEM) image of the 9 silicon nanowires that  
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Figure 3.2 (Continued). constitute the active region of a VNEA. Dimensions of the nanowire 
electrodes were designed to facilitate single-cell intracellular electrical coupling. False coloring 
shows metal-coated tips (gray) and insulating silicon oxide (blue). Scale bar, 1 µm. b, SEM 
image of a VNEA pad. False coloring indicates additional insulation by Al2O3 (green). Scale bar, 
10 µm. c, SEM image of a device consisting of 16 stimulation/recording pads for parallel multi-
site interrogation of neuronal circuits. Scale bar, 120 µm. d, SEM image of a rat cortical cell (3 
days in vitro (DIV), false colored yellow) on top of a VNEA pad (false colored blue), showing 
nanowires interfacing with the cellular membrane (inset). e, Reconstructed three-dimensional 
confocal microscope image of rat cortical neurons cultured on a VNEA pad (3 DIV). f, 
Representative optical microscope image of calcein AM-labeled rat cortical neurons (cyan) 
cultured on a VNEA (5 DIV). 
 
The top-down nanofabrication technology employed here enables precise control over the 
physical dimensions of the nanowires, as well as the size and the configuration of the 
stimulation/recording pads. Moreover, the number of pads can easily be scaled up to the 
thousands. By virtue of its planar integrated geometry, the VNEA is well suited for studying in 
vitro dissociated neuronal circuits and quasi-2D ex vivo preparations, like brain slices or retina. It 
can also be readily coupled with fluorescence microscopy44,115, optogenetic techniques50, and 
conventional patch measurements60, allowing truly multiplexed interrogation of neuronal 
circuits. As an example, Fig. 3.2f shows a typical network of dissociated rat cortical neurons on 
top of a VNEA after five days in vitro (DIV). Images obtained via confocal microscopy 
demonstrate that the neurons sitting directly on top of the nanowires envelop them and, at times, 
appear penetrated (Fig. 3.2e and Fig. 3.3). Meanwhile, whole cell patch clamp measurements 
show that neurons cultured on the VNEAs have similar electrophysiological characteristics as 
those cultured on glass cover slips, as previously observed89. 
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Figure 3.3 | Nanowire penetration of neuronal cell membranes. Three-dimensional confocal 
reconstructions show that the membranes of some neurons (orange) appear penetrated by 
nanowires (white) (A, B), while others appear to rest on top of the nanowires (C, D). 
 
3.3 Optimization of Operation Protocols 
We optimized operation protocols for our VNEA devices using HEK293 cells as a model 
system. HEK293 cells are advantageous for establishing stimulation and recording procedures 
because they require a short culture time before electrical interrogation (only a few hours), and 
their membrane resistance remains constant within 15 mV of the resting membrane potential116. 
To determine the device parameters that characterize the VNEA-cell interface, we performed 
whole-cell patch-clamp recordings of HEK293 cells residing directly on top of the nanowires 
and monitored voltages and currents simultaneously using both a patch pipette and a VNEA pad 
(Fig. 3.4a). In more than half of the cases, the membrane potential changed immediately upon 
VNEA current injection, suggesting that the nanowires had spontaneously penetrated the cell’s 
membrane. When the membrane potential of a cell did not change significantly upon current 
injection (i.e. when the nanowires were not inside the cell), we used a short voltage pulse (~ ±3 
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V, 100 ms duration) to permeabilize the cell membrane117 and promote nanowire penetration (see 
Methods). 
 
 
Figure 3.4 | Characterization of the VNEA-cell electrical interface. a, Composite bright field 
and fluorescence image of a patched HEK293 cell on a VNEA pad (0 DIV). Calcein (green) was 
added to the intracellular recording solution to enable fluorescence imaging of the patched cell. 
b, In both capacitive and Faradaic modes, the voltage response of the cell due to pipette current 
injection (Ip) (red) was recorded simultaneously using a patch pipette (Vp, blue) and a VNEA pad 
(VNW, magenta). Similarly, the cell’s membrane potential could be controlled (as verified by 
patch pipette recordings) by injecting current through the nanowires (INW) (orange). Note that 
capacitive and Faradaic measurements were performed on different cells since switching 
between recording modes required swapping amplifier electronics. c, Equivalent circuit model of 
the VNEA-cell interface. Ra,NW and Rs,NW (Ra,p and Rs,p) represent the access and seal resistances 
for the nanowires (pipette), respectively. The capacitance of the electrical double layer at the 
nanowire surface is represented as CNW. The equivalent circuit also includes the leak resistance 
due to uncoupled nanowires or defects in electrode insulation (RL) and the parasitic capacitance 
due to the device and associated electronics (Cp). The cell itself has a characteristic membrane 
resistance (Rm), capacitance (Cm) and resting potential (Vrest), all of which combine to determine 
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Figure 3.4 (Continued). the potential across the cell membrane (Vm). The values of these circuit 
elements were determined based on simultaneous patch pipette and VNEA measurements such 
as those shown in b.  
 
Once the nanowires had access to the cell’s interior, the VNEA device was used to 
measure and control the cell’s membrane potential (Vm) by leveraging electrochemistry at the 
nanowire tips. Specifically, when no voltage was applied to the nanowires, the change in Vm 
induced by the patch pipette led to a change in the nanowire voltage (VNW) due to the 
charging/discharging of the electrical double layer at the metal-coated nanowire tips (the 
“capacitive” regime: Fig. 3.4b left column). Changes in Vm could also be recorded by applying a 
bias (~ -1.5V) to the nanowires that was sufficient to flow a small electrochemical current – in 
this “Faradaic” regime, the value of VNW required to maintain a fixed current tracked the changes 
in Vm, in a fashion similar to conventional current-clamp techniques60 (Fig. 3.4b center column). 
Finally, when current was injected through the nanowires, the voltage measured at the patch 
pipette (Vp) changed (Fig. 3.4b, right panel and Fig. 3.5), indicating that NW-based control over 
the membrane potential is also possible (we note that because the nanowires provide only a small 
point source of current, changes to the membrane potential may not be uniform throughout the 
cell). In the Faradaic regime, when current was injected through the pipette (nanowire), voltage 
changes measured at the nanowire (pipette) were ~3 (~10) times smaller than those measured at 
the pipette (nanowire). In the capacitive regime, on the other hand, VNW was ~300 times smaller 
than Vp. 
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Figure 3.5  |  Steady state control of the membrane potential. The membrane potential in a 
0DIV HEK293 cell recorded via patch pipette (Vp, magenta) can be controlled by changing the 
offset voltage applied to the nanowire electrode (VNW, blue) 
 
During capacitively coupled measurements, Vp typically rose by ~10 mV from the initial 
resting potential after 30 minutes of recording. Such a rise was common even for patch pipette 
recordings without nanowire penetration, suggesting that the duration of our measurement was 
limited not by the nanowire recording but rather by effects from patching. During capacitive 
measurements, a reduction in the signal amplitude measured at the nanowires was also observed 
over the course of few minutes, indicating partial recovery of the permeabilized membrane. 
However, this signal could be repeatedly restored to full strength by reapplying the 
permeabilization protocol. In the Faradaic regime, no signal reduction was observed, likely due 
to the constant current flow at the nanowire tips. It should be noted that, unlike capacitive 
measurements, the continuous recording time in the Faradaic regime was typically limited to less 
than 10 minutes, most likely due to prolonged electrochemical reactions damaging the cellular 
membrane. By performing measurements intermittently, however, the interrogation period could 
be extended significantly. 
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3.4 Equivalent circuit analysis of the VNEA-cell interface 
Analysis of the current/voltage traces measured at the patch pipette and the nanowire 
(Fig. 3.4b and Fig. 3.6) using the equivalent circuit model in Fig. 3.4c enabled the determination 
of all of the parameters that specify the electrical coupling between the cell and the nanowires. In 
particular, this analysis showed that the seal resistance (Rs,NW) between the nanowires and the 
cell membrane ranged between 100 and 500 MΩ, and the total double-layer capacitance at the 
nanowire tips (CNW)118 was typically ~1 pF. The nanowire access resistance (Ra,NW), which 
includes the intrinsic nanowire resistance and the resistance at the electrochemical junction and 
thus varies with VNW, was determined to be infinite at zero bias (no electrochemical reactions 
occurs at the metal tips) and ~300 MΩ at VNW ~ -1.5 V. When the measurement was performed 
in the Faradaic regime, this large Ra,NW, combined with the parasitic capacitance (Cp) of a typical 
VNEA pad and its associated electronics (~150 pF), resulted in an RC time constant on the order 
of 10 ms. Although this RC component filtered the voltage waveform measured at the nanowires 
(as compared to that measured at a patch pipette), this distortion could be easily corrected using a 
deconvolution procedure (Fig. 3.6, 3.7). In the capacitive regime, the change in VNW originated 
from the charging and discharging of the electrical double layer and thus accurately followed fast 
changes in Vm. The magnitude of this response, however, was attenuated due to capacitive 
voltage division (~CNW/Cp). 
Herein we depict in more details how the values of the circuit elements shown in Fig. 
3.4c were determined using the input impedances of the patch pipette and the VNEA pads, as 
well as the electrical coupling between the two. After forming a seal with the patch pipette (prior 
to membrane rupture), the pipette seal resistances (Rs,p) were measured to be >2 GΩ based upon 
the steady state current resulting from 10 mV test pulses applied to the patch pipette. The pipette 
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access resistance (Ra,p), membrane resistance (Rm) and membrane capacitance (Cm) were then 
measured from transient current responses to 10 mV test pulses after rupture using the pCLAMP 
10 software (Molecular Devices) and Matlab. Values of Ra,p were typically between 15 and 30 
MΩ, within the normal range for the 5 ~ 10-MΩ patch pipettes used in our experiments. Because 
this value was small compared to Rs,p, currents through the pipette seal were neglected from the 
subsequent analysis. Typical Rm and Cm values for HEK293 cells were between 150 ~ 600 MΩ 
and 10 ~ 30 pF respectively, consistent with those reported in literature22.  
After obtaining a whole cell patch with a pipette, current injected through the pipette (in the 
current-clamp mode) and the VNEA were used to determine the values of the remaining circuit 
elements. The nanowire seal resistance (Rs,NW) was determined to be 100 ~ 500 MΩ based on the 
change (ΔRin,p) in the access-adjusted pipette input impedance (Rin,p ≡ [1/Rm +1/Rs,NW]-1) before 
(Rin,p0) and after (Rin,p1) membrane permeabilization at the nanowire-cell junction (Fig. 3.6): 
. 
  
Figure 3.6 | Membrane characteristics before and after permeabilization. Typical voltage 
response to 50-pA current pulses before (blue) and after (magenta) membrane permeabilization 
at the nanowire-cell junction. Measurement and stimulation were performed on a HEK293 cell (0 
DIV) using a patch pipette in whole-cell current-clamp mode. 
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The ratio (κp) between the pipette voltage change (ΔVp) and the nanowire voltage change 
(ΔVNW) during nanowire current injection can be related to the nanowire access resistance 
(Ra,NW) and the leak-adjusted nanowire input impedance (Rin,NW ≡ RNW + [1/Rm +1/Rs,NW]-1) by: 
. 
Note that similar to the pipette access resistance, Ra,NW includes the intrinsic nanowire electrode 
resistance, the resistance at the electrochemical junction, and the resistance through the 
permeabilized membrane interface.  
Meanwhile, the ratio (κNW) between ΔVNW and ΔVp during current injection via the 
pipette can be related to Ra,NW and the VNEA leak resistance RL (either through defects in 
electrode insulation or uncoupled nanowires) by: 
. 
Typical values for κNW and κp in our experiments were 0.2 ~ 0.5 and 0.04 ~ 0.1, respectively. 
From these measured values, we can calculate the Ra,NW and the RL: 
, 
. 
Ra,NW and RL typically ranged between 0.3 and 1.5 GΩ, consistent with the total nanowire input 
impedance Rt ≡ RNW + [1/RL +1/Rin,NW]-1 measured experimentally. Note that due to 
electrochemical reactions at the nanowire tip, Ra,NW is a nonlinear function of VNW, and the value 
presented above represents those determined at a typical operating voltage of -1.5 V with respect 
to the bath electrode. 
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RC time constants of the VNEA measurement setup  
Bare nanowire RC time constants were measured as follows. At the conclusion of a 
recording session, the patched cell was removed from the recording pad by slowly withdrawing 
the patch pipette. The current flowing through the nanowires was then increased by 200 pA for 
300 ms and the corresponding voltage change was recorded. The transient portion of the 
response could be well described by a single exponential with a time constant between 5 and 50 
ms. We determined the nanowire resistance from the steady-state potential difference at the two 
nanowire currents. Dividing the exponential time constant by this resistance yielded the value of 
the parasitic capacitance (Cp), which was typically 150 pF.  We determined the parasitic 
capacitance of our current-clamp electronics to be 50 pF by applying the same protocol using a 1 
GΩ load resistor. 
Using the measured RC time constant of a VNEA pad, we could deconvolve voltage 
waveforms measured by the VNEA pad and recover true membrane potential waveforms. As an 
example, we used a model action potential (AP) waveform to control the membrane potential of 
a HEK293 cell. The time-averaged VNEA recording is shown in Fig. 3.7. To recover the original 
waveform, we rescaled the measured signal according to the measured coupling constant (κNW) 
and performed a Weiner deconvolution in Matlab using the measured time constant of 9.3 ms. 
The deconvolved VNEA measurements showed good agreement with the original waveform 
applied to the pipette (Fig. 3.7). 
 
Figure 3.7 | Deconvolution of VNEA measurements. A model AP waveform generated via a 
patch pipette is measured using the VNEA in current-clamp mode (magenta). Deconvolution of 
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Figure 3.7 (Continued). the VNEA measurement (orange) shows good agreement with the 
waveform applied at the patch pipette (blue). Plots are averaged over 5 recordings. 
 
 
3.5 High-fidelity Intracellular Stimulation and Recording of Rat Cortical Neurons 
Once the device characterization and protocol optimization were complete, we utilized 
the VNEA to perform high-fidelity intracellular stimulation and recording of rat cortical neurons 
(Fig. 3.8). Typically, these neurons were interrogated after 6 to 14 DIV to allow 
electrophysiological development and the formation of synaptic connections119,120. As shown in 
Fig. 3.8c, current pulses injected into neurons via the nanowires reliably evoked neuronal action 
potentials (APs) as recorded via simultaneous whole-cell patch clamp. The stimulation 
probability followed a sigmoidal dependence on the magnitude of the nanowire-injected current 
(Fig. 3.8b), similar to that reported for patch pipette stimulation121. Moreover, the VNEA 
operating in current-clamp mode could be used to monitor individual APs evoked by the patch 
pipette. For single-shot AP measurements, the signal-to-noise ratio for VNEA recordings was 
typically 100 or greater (Fig. 3.8d). When we averaged multiple waveforms obtained under 
identical experimental conditions, we could improve the signal-to-noise ratio to >1000 (Fig. 3.7). 
This suggests that by averaging the response to repeated presynaptic stimulations, postsynaptic 
potentials (PSPs) could be measured using the VNEA. 
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Figure 3.8 | Stimulation and recording of rat cortical neurons using a VNEA. a, 
Representative differential interference contrast micrograph of a rat cortical neuron cultured on a 
VNEA pad (6 DIV). b, Probability of action potential (AP) excitation plotted as a function of 
current injected by nanowires shows a sigmoidal dependence (dashed line), which is similar to 
AP excitation elicited via intracellular patch pipettes. Probabilities were calculated for 20 trials 
and plotted as a function of the stimulation current. Error bars represent 95% confidence 
intervals. inset, 5 consecutive time-aligned APs stimulated by nanowire current injection show 
less than 1-ms jitter. c, APs were reliably stimulated by voltage pulses at the VNEA pad 
(magenta) and recorded using a patch pipette (blue). d, Similarly, APs were stimulated using a 
patch pipette (blue) and recorded by the VNEA pad in the Faradaic mode (magenta). VNEA 
measurements show good agreement with those obtained simultaneously via patch pipette. 
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3.6 Functional Connectivity in Neuronal Circuits 
The multiplexed stimulation and recording capabilities of the VNEA platform and its 
compatibility with conventional patch-clamp and fluorescence microscopy techniques enable 
comprehensive examination of the functional connectivity in neuronal circuits beyond traditional 
connected-pair studies122. To illustrate the potential of such measurements, we used our VNEA 
platform to map multiple individual synaptic connections onto a single postsynaptic neuron. 
Specifically, we used a patch pipette to measure the PSPs of a single neuron in a dissociated 
neuronal culture while inducing APs in other neurons using neighboring VNEA pads (Fig. 3.9a). 
By monitoring PSP responses upon repeated stimulations at each pad, we found that excitation of 
some of the nearby neurons reproducibly generated either excitatory (EPSPs) or inhibitory PSPs 
(IPSPs) in the patch-clamped cell (Figs. 9b and 9c). The latency window of these EPSPs and 
IPSPs ranged from 2 to 8 ms, indicative of a monosynaptic connection123. We note that 
performing this type of measurements using conventional patch clamp techniques would require 
each pre-synaptic cell to be individually identified and patched separately. Using our VNEA 
platform, this process can be significantly simplified and expedited. Together, the magnitude, 
sign, and latency of these PSPs define the functional connectivity of a neuronal circuit. By 
monitoring changes in this connectivity as a function of time and combining it with structural 
reconstruction techniques, we should be able to investigate the relationships between the 
architecture, dynamics, and function of neuronal circuits in unprecedented detail. 
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Figure 3.9 | Identification of functional synaptic connectivity using a VNEA and a patch 
pipette. a, Composite bright field and fluorescence image of a cortical neuron patched and 
backfilled with calcein (14 DIV). b, Representative EPSPs (top) and IPSPs (bottom) were 
averaged (bold) and used as templates for identifying other PSPs recorded via a patch pipette. To 
measure these PSP events, we injected a constant current through the patch pipette to hold the 
membrane potential near -40 mV. At this resting potential, EPSPs and IPSPs produce positive or 
negative changes in the membrane potential respectively, allowing them to be distinguished from 
one another. c, Raster plots of EPSPs (red) and IPSPs (blue) identified by patch-clamp recording 
and plotted as a function of their latency following stimulation at the specified VNEA pads. Each 
of the five pads shown here evoked reproducible PSPs in the patched cell within a latency 
window of 2 - 8 ms (green), suggesting monosynaptic connectivity. 
 
3.7 Conclusions and Prospects 
 The present study demonstrates that the VNEA platform provides new 
experimental methods to stimulate and record neuronal activities in a highly scalable fashion. 
Moreover the VNEA platform can be readily coupled with conventional patch measurements, 
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fluorescence microscopy, and optogenetic techniques, allowing truly multiplexed interrogation 
of a neuronal circuit. Although the prototype demonstrated here has only 16 
stimulation/recording sites, higher numbers and densities can easily be achieved using standard 
silicon nanofabrication processes. For instance, contemporary deep UV lithography with feature 
sizes near 150 nm can produce recording pad densities approaching 10,000 electrodes/mm2. The 
integration of complementary metal-oxide-semiconductor circuitry with a VNEA would further 
allow on-chip digitization, signal multiplexing, compression, and telemetry. Finally, the small 
dimensions and planar geometry of VNEAs should facilitate their incorporation into implantable 
electrodes, similar to the silicon-based microelectrode array implants currently in use124, opening 
up new possibilities for neuronal prosthetics and large-scale studies of neuronal circuit dynamics 
in vivo. 
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CHAPTER 4 
 
CMOS-Nanoelectrode Array: A Fully Integrated Platform 
to (1) Map and Modify the Functional Connectivity of 
Complex Neuronal Networks and (2) Enable High-
throughput Drug Screening of Neurological Disorders 
 
4.1 Introduction 
Our prototype device with 16 recording/stimulation sites demonstrated that vertical nanowire 
electrode arrays enable direct intracellular electrical access to mammalian neurons in a minimally 
invasive fashion127. The development of the VNEA as a highly scalable intracellular electrode platform 
paved the way towards novel nanotechnologies that facilitate large scale measurements of the functional 
connectivity of neuronal networks114. To further expand and improve upon this prototype device we 
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moved towards the development of a fully integrated CMOS-nanoelectrode array (CNEA) that is capable 
of measuring and controlling a large number of neurons with single-cell resolution. The design of our 
CNEA aims to generate the new neuro-nanoelectronic interface to: (1) map and modify the functional 
connectivity of complex neuronal networks in vitro and ex vivo and (2) screen candidate drug treatments 
for neurological disorders in a high-throughput fashion. 
Advanced CMOS technology has been recognized for its potential and integrated in platforms for 
neuronal network studies in several configurations; for example, (1) foundry-fabricated CMOS chips with 
high-density microelectrode arrays for in vitro neuronal networks and (2) CMOS chips combined with the 
Utah MEA for in vivo neuronal networks128-134. Despite the high-density recording capability 
characterizing these platforms (up to ~16,000 active sites), neuronal signals were measured only at a 
small number of sites and were not directly correlated. Being based on extracellular neuronal recordings, 
these studies were unable to obtain signal-to-cell registry or a detailed description of network dynamics in 
complex neuronal circuits. 
The overall design and aimed functionality of our CNEA device is a significant departure from 
previous CMOS-microelectrode arrays: unlike the previous devices that performed extracellular 
recordings, our CNEA will monitor and stimulate signals intracellularly, thereby enabling the 
unambiguous cell-to-electrode registry essential for functional mapping of large numbers of 
interconnected neurons135,136. The front side of the array features 1024 recording/stimulation sites, each 
equipped with NWs for neuronal coupling (the length of the NWs will vary from 3 µm for in vitro culture 
studies to 30 µm for ex vivo tissue studies, and the site numbers will vary accordingly). The backside of 
the array will contain the CMOS integrated circuits (ICs) that perform amplification and processing of 
neuronal signals. In addition, the CMOS chips include the additional circuit that enables each pixel to 
pass a voltage pulse for stimulating neuronal activity. By applying specific electrical stimulation to each 
pixel individually, we will be able to excite neuronal networks with a broad range of spatiotemporal 
patterns. Thus, each recording/stimulation site (pixel) in the array will contain nanowires on top, and a 
low-noise amplifier, a stimulator, and digital circuits in the underlying IC. The IC will play a critical role 
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in enabling parallel operation of the nanoelectrode array and will thus propel it as a practical forefront 
tool in neuroscience. Also, the proximity of the IC to the nanoelectrodes will ensure the sensitivity 
promised by the intracellular recording. In sum, the CMOS-assisted nanoelectrode array will make 
possible both parallelism and high-sensitivity intracellular recordings. 
4.2 CNEA Top Fragment: Large array of electrically active vertical nanowire electrodes 
One of the defining characteristics of our CNEA device is its ability to intracellularly interface 
with a large number of neurons via its front-side vertical nanowire electrodes. The definition and 
generation of the front nanoelectrode cellular interface array is achieved via a multi-level and complex 
nanofabrication process to produce an efficient interface between biological neuronal networks and the 
underlying electronic circuitry. The complexity of the nanofabrication process is a necessity due to the 
complementary metal–oxide–semiconductor (CMOS) technology that can withstand full functionality if 
exposed only to temperatures below 450°C. In addition, the functional goals of the final device layout – a 
cellular interface that is intracellular, individual, and parallel – further extend the nanofabrication 
requirements and limitations. Our fabrication process, summarized in Fig. 4.1 below, makes possible the 
achievement of our ultimate functional aims in parallel to preventing any physical or functional damage 
to the underlying CMOS chip.  
 
Figure 4.1 | Summarized fabrication process-flow 
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Initially, to prevent any functional or physical damage to the CMOS chip, we begin the 
fabrication process by protecting the CMOS exposed Aluminum-metal-layer-4 (Al-4) via sputter 
deposition of a Titanium (Ti) and Platinum (Pt) metal layer. Our optimally thick and high-resolution Ti-Pt 
protection layer ensures: (1) inhibition of any chemical attacks of the exposed Al-4 possible during etch 
processing, (2) prevention of the Al-4 diffusion to the top of the protection layer during high temperature 
processes, and (3) production of a high-quality underlying material that supports the generation of the top 
nanowire electrodes by ensuring a good adhesion between the deposited silicon dioxide (SiO2) and the 
substrate.   
Secondary, to facilitate the generation of high-quality structural material for the nanowire 
electrodes and prevent any impairment of the CMOS chip we developed a non-standard plasma-enhanced 
chemical vapor deposition (PECVD) of SiO2 at a temperature of only 350°C. Our developed PECVD 
process includes: (1) ensuring a highly clean substrate, (2) stabilizing the chamber vacuum, (3) ensuring a 
plasma chamber uniformity, (4) establishing a stable plasma prior to the deposition start, and (5) 
maintaining a low silane to nitrous ratio. To fabricate the vertical nanowire electrode array for interfacing 
two-dimensional in vitro cultures, at the previously determined optimal height, we first deposit 3.5µm 
SiO2 via this PECVD process, which gives rise to an excellent uniformity and structural quality material 
with strong adhesion to the underlying pixel metal.  
Consequently, we optimized stepper lithography to allow the generation of the accurately aligned, 
widely uniform (across the large pixel array), and high quality etch mask. We used the optimized stepper 
lithography process to generate the array of the etch mask consisting of photoresist discs 1µm in diameter 
– aligned centrally on top of the active pixel array. Such an etch mask facilitates the generation of the 
highly uniform array of vertical nanoelectrodes via reactive ion etching (RIE) of the surrounding SiO2 
surface. Once the characteristics of the RIE process were characterized and subsequently improved, we 
achieved a highly selective and reproducible SiO2 etching that facilitated the generation of initial vertical 
structures with high aspect ratio and the designed vertical etch profile. Subsequently, SiO2 isotropic wet 
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etching is used to achieve the final structural profile of the vertical nanowire (length, 3µm; diameter, 
100nm).  
Next, electrical activation of the tips of the vertical nanowire electrodes in addition to conductive 
connection with the underlying metallized pixel is achieved through selective and conformal 
metallization. Contact lithography followed by sputtered metallization allows the generation of a uniform 
metal layer with high conductivity and small grain size. The whole chip is insulated by 20nm SiO2 and 
200nm Al2O3 (via atomic layer deposition – ALD) to prevent currents leaking from the metal pads and 
reduce parasitic capacitance. Selective Al2O3 etching via photolithography and wet etching enables us to 
remove the Al2O3 only on nanowires and a small region around it, and stop at the SiO2 layer. The 
exposure of the nanowire metal tip is achieved by spincoating photoresist to protect the nanowire base 
and subsequently wet etching the SiO2 at the selectively exposed tip. The final results of the fabrication 
process are summarized in Figure 4.2.  
 
Figure 4.2 | Scanning electron microscope (SEM) images of increasing scale showing vertical nanowire 
electrodes post-fabricated on each pad. 
 
 
The design, development, and optimization of our nanofabrication process-flow facilitated the 
generation of our efficient interface between biological neuronal networks and the underlying electronic 
circuitry. First, the ultimate profile geometry of the vertical nanowires, shown in Fig. 4.2 a, makes 
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possible the intracellular interface of individual neurons. Secondly, the electrical properties of these 
nanoelectrodes (electrochemically active nanowire tips (color), selectively insulated base, and 
conductively connected to the underlying pixel circuitry) provide the direct electrical access to the cell’s 
interior with minimal effect on cellular viability. Thirdly, Fig. 4.2 c depicts the fabrication of the uniform 
nanoelectrode array (geometrically and electrically) across the CNEA chip, which allows the generation 
of 1,024 independently addressable recording/stimulation sites at a 126 µm pitch over a 16 mm2 area.  
4.3 CNEA Underlying Circuitry: CMOS ICs 
The backside of the CNEA contains the CMOS circuits that perform amplification and processing 
of neuronal signals. The implementation of in situ amplifiers proximate to the nanowires makes possible 
the reduction of signal attenuation by eliminating lengthy interconnects. Each pixel records the voltage 
signal generated by a neuron as detected by the front-side NWs. In addition, the CMOS circuits are 
designed so that each pixel can pass a voltage pulse for stimulating neuronal activity. By applying 
specific electrical stimulation to each pixel individually, we will be able to excite neuronal networks with 
a broad range of spatiotemporal patterns. The underlying CMOS chip of our CNEA devices was designed 
and fabricated in the 0.35 µm node of Taiwan Semiconductor Manufacturing Company (TSMC), using 
the high breakdown voltage metal–oxide–semiconductor field-effect transistor (MOSFET) option with 
top/bottom power rails of ±2.5 V. Individual CNEA chips contain 1024 stimulation/recording sites 
enabling large-scale interfacing of neuronal networks, with single cell resolution. The CMOS IC design 
considerations – associated with the required functionality of individual pixel circuitries – determined the 
pitch between two adjacent recording/stimulation sites to be 126 µm137. Thus, the individual 10x10 mm 
CMOS chip contains a ~ 4x4 mm active area consisting of a 32x32 pixel array as represented in blue in 
the chip micrograph shown in Figure 4.3b.  
	  55	  
	  
 
Figure 4.3 | (a) Image showing the 8-inch wafers containing the CMOS chips. (b) CMOS chip 
micrograph; in the middle is the 32x32 pixel array (represented in blue color); a zoom in of four shown on 
the right. Control circuitry is then located around the array, which programs the memory at each pixel and 
run the output multiplexer (green color coded). Further outside, the I/O pads and alignment marks used 
for post- fabrication (yellow and red, representation).   
 
 
The IC design goals that determined the overall layout of the active array included: (1) a two-way 
interface with neurons for both recording and stimulation of electrical activity, (2) high Signal-to-Noise 
Ratio (SNR) recordings for each of the individual sites, (3) simultaneous, low-energy operation of the 
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active array for biocompatible and high-throughput interrogation capability of neuronal networks. First, 
the dual pixel functionality (capability of both stimulating and recording modes) is achieved via two 
separate circuitries, as shown in the summarized circuit schematic (Fig. 4.4), combined with digital 
control circuits that enable the activation/deactivation of the selected functional mode. The pixel layout of 
the CNEA underlying IC shows the optimized design and circuitry arrangement in individual pixels (Fig. 
4.4 b). 
 
Stimulation mode 
The central components of the stimulation circuitry, colored in blue in Fig. 4.4, consist of an op-
amp with a unity gain feedback (a voltage buffer) whose output is controlled by the memory in 
conjunction with the multiplexer (MUX). The stimulation voltage signals drive the nanoelectrode by the 
direct injection or draw of a current (no de-coupling capacitor between the stimulator and electrode) 
directly to or from the neuron through the access resistance (Ra). The stimulation mode circuitry is 
characterized by a <0.1 ms settling time (faster than the membrane response) and enables stimulating 
currents over a wide range up to 4 V. Independent control on three variable voltage signals for stimulation 
on individual pixels enables a wide variety of stimulating schemes for network level studies.  
 
	  57	  
	  
 
Figure 4.4 | (a) Electrical block diagram. Nanoelectrode and underlying pixel circuitry showing 
equivalent circuit models of the neuronal membrane (membrane potential, Vm, membrane resistance, Rm, 
membrane capacitance, Cm, and resting potential, Vrest) and nanowire-electrolyte interface modeled as a 
double layer capacitance, Ca, and faradic resistance, Ra, with noise source, Vn, and power spectral density 
per hertz of bandwidth, Vn 2/Δf, of 4kTRa (k is Boltzmann’s constant and T is temperature). The pixel is 
composed of the reading amplifier (green/right) and stimulator (blue/left) with digital control circuits 
(bottom) to allow for enabling or disabling the stimulator or amplifiers, gain, and choice of stimulation 
signal. (b) Top-view of pixel layout.  
 
 
Recording mode 
The circuitry of the recording mode, detailed in Fig. 4.5, was designed to meet the sensitivity and 
performance requirements necessary to account for the wide variety of signal properties and to overcome 
the attenuation and noise generated from several sources. Signal attenuation arises from the properties of 
the top electrode (from active and parasitic coupling) in combination with the properties of the underlying 
amplifiers. The nanowire electrode can be modeled with a Faradic resistance, Ra that varies with the 
electrode’s DC current, in parallel with a capacitance, Ca of the electrode/electrolyte double layer formed 
at their interface. To prevent damage to cell viability, the NWs are operated at zero DC current. In this 
configuration, we achieve capacitive coupling to the intracellular signals through the double layer 
capacitance, the impedance of which, 1/(jωCa), is on the order of 0.1 GΩ ~ 0.1 TΩ in the 
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electrophysiological signal bandwidth of 1 Hz ~ 5 kHz138. Despite the relatively lower impedance 
compared to the Faradic resistance (~10 TΩ), capacitive coupling is associated with significant signal 
attenuation due to voltage division with parasitic capacitances of the metal pad and subsequent 
interconnects, summed up as Cp  (Fig. 4.4). This necessitates an optimal interface with the input 
impedance of the amplifier to minimize further signal attenuation in addition to an optimized amplifier 
overall design to facilitate signal amplification well above subsequent transmission noises. Furthermore, 
the 1/f amplifiers’ noise significantly affects the biological signals due to their low amplitude and low 
frequency.  
To address these challenges, high SNR recordings of electrical signals is achieved via a two-stage 
amplifier design consisting of (1) a front-end low noise amplifier (LNA) and (2) variable gain amplifier 
(VGA) (Fig. 4.5, right). Each of the LNA and VGA consists of a single-ended two-stage operational 
amplifier topology with a minimal number of transistors to reduce overall 1/f noise contribution from the 
circuit. The overall two-stage amplifier acts as a bandpass filter (closed-loop configuration with a 
passband gain of C1/C2), with a bandwidth 0.1 Hz – 5 kHz including the wide frequency range associated 
with the biological signals while filtering out most low-frequency 1/f noise and high-frequency noise 
beyond 5 kHz139. Turning on the recording mode results in the simultaneous activation of the first and 
second stage of LNA via the two current sources I1 and I2 in addition to activating and setting the VGA 
similarly. The front-end amplifier (stage 1) is an op-amp with a negative feedback loop and with an AC-
coupled input to the top nanowire electrodes. AC coupling the front end of the amplifier to the nanowire 
electrodes, through C1 = 200 fF, generates a high nanowire faradic resistance (~TΩ, Teraohms), thus 
preventing any direct currents in recording mode. The nanowire electrode is portrayed by the capacitor 
generated by the double layer formed between the nanowire electrode and cellular electrolyte (Ca, 10-
100fF). The implementation of these capacitive measurements enables long-term recording capabilities by 
eliminating any cellular damage caused by continuous current injections/draws.  
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Figure 4.5 | Detailed schematic of the pixel circuitry with nanoelectrode. In addition to the noise 
produced by the amplifier, the nanoelectrode’s resistance produces noise that is referred to the input of the 
amplifier. To accomplish a low frequency pole to reduce low frequency 1/f noise, a pseudo resistance 
composed of diodes is used in the feedback path allowing for greater than teraohm resistance or less than 
a 0.1 Hz pole. 
 
The op-amp, internally, consists of a two-stage configuration with the first differential and second 
single-ended stage assuming a common-source topology with active loads. Input transistors (M1 and M2) 
are p-type metal-oxide-semiconductor (PMOS) transistors; they are chosen because of their smaller 1/f 
noise compared to the typical n-type metal-oxide-semiconductor NMOS transistors, as PMOS transistors 
are built in n-wells that isolate the amplifier input from substrate noise. Furthermore, their configuration 
suppresses noise that is generated from fluctuations in the top power rail, VDD = 2.5 V. Additional noise, 
generated via fluctuations in the bottom power rail Vss = -2.5 V, is suppressed through the cascode 
transistors (M3, M4) at the amplifier output. Even though the cascoding configuration introduces another 
bias line (Vbias), it draws no current, thus a stable voltage reference can make it quiet.  
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On the other hand, the negative feedback loop contains a high-pass filter – a diode pseudo resistor 
(Rpseudo) in parallel with a poly-insulator-poly capacitor (C2) defining a 5-Hz 1-pole cutoff. It filters in 
most spectral contents of the electrical activity of cells to enable high fidelity in signal acquisition, while 
at the same time it filters out DC drifts and near-DC 1/f noise to prevent saturation of subsequent 
amplifiers. The incorporation of the pseudo resistance composed of a series of diodes, which provides a 
very high resistance within the limited pixel area, enables the creation of the low frequency pole. 
Additionally, the negative feedback loop sets the bias for the gate of input transistor M1 at Vref (the gate of 
M2 is directly biased at Vref). The array is split (top and bottom) using two different LNA amplifiers; the 
top half LNA has a measured passband voltage gain of ~20 V/V by design while the bottom half LNA is 
~8 V/V. 
The second stage of the recording-mode circuitry consists of a VGA with the double role of (1) 
enabling high SNR of the wide electrical signal range for routing off the chip for data acquisition, and (2) 
providing low-pass signal filtering with a 10-kHz 1-pole cutoff, suppressing any noise above the sampling 
rate. It has a designed digitally tunable measured gain (4 bits, Gain [1:4]) from ~1.25 V/V to ~20 V/V 
with an increment of ~1.25 V/V to adjust signal dynamic range. Adjusting the VGA’s gain through a 
control voltage facilitates two extreme case scenarios: at its highest settings the recording of low 
magnitude signals (PSP ~ 1mV) and at its lowest settings the large magnitude signals (APs ~ 100mV) 
without causing saturation. In addition, by providing this variability in voltage gain, it allows adjusting 
for signal attenuation resulting from variability in the top nanowire electrodes as well as their interface 
with the biological cells.  
The pixel operational mode and variability is controlled through a 10-bit digital memory. The 10 
static random-access memory (SRAM) cells store rewritable data that define the overall operational 
settings of individual pixels. First, they define the pixel operation mode into recording, stimulation, or off 
through enabling/disabling specific amplifiers. Second, they select the specific stimulus to define the 
particular stimulation experiment. Third, they set the gain of the VGA to control the overall signal 
amplification in recording mode, thus accounting for attenuation variations from pixel to pixel. 
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4.4 Overall Experimental Set-Up 
Device packaging for culture compatibility 
Specialized packaging technology was developed to generate the final experimental platform for 
cell culture compatibility, leaving exposed the nanoelectrode array while completely isolating the rest of 
the electrically active components. Individual chips are mounted on ceramic chip-carriers through low-
height wire bonding to allow for the subsequent high-quality encapsulation. Next, a square Si ring (0.5 
mm high and 0.5 mm wide) surrounding the active central array area is attached via biocompatible epoxy 
to form the main chamber for cellular culture directly on top of the active array. A larger glass ring (outer 
diameter 34mm, width 3mm, height 5mm) is used to form the chamber for media supplement. 
Subsequently the wire bonds located in the region between the inner (Si) and the outer (glass) rings are 
encapsulated with PDMS to completely isolate them from the highly conductive medium. The material 
arrangement of the overall chip package allows the generation of a substrate fully supportive of viable 
cellular cultures while the structural design facilitates complete compatibility with standard 
electrophysiological setup including patch clamp and fluorescent imaging (Fig. 4.6).  
            
Figure 4.6 | Packaging: (a) CMOS-nanowire array chip is wire-bonded to a chip carrier; a glass ring and 
PDMS flowed over the wire-bonds create a microfluidic well for cell culture. (b) Experimental setup 
including the packaged CMOS-nanowire array chip, custom designed PCB, patch clamp, and 
fluorescence microscope. 
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Printed circuit board (PCB), external circuitry and software 
The fully packaged device on the chip carrier is inserted into a custom designed PCB connecting 
to further downstream electronics, thus facilitating control and optimization of its overall functionality. 
Using a data acquisition card (DAQ, National Instruments PXIe-6358) connected through the PCB, the 
pixel’s digital memory is programmed and the analog output multiplexers are controlled (allowing for a 
pixel to be addressed and directly connected to the output, which enables an individual pixel to be 
sampled at a much higher sample frequency if desired). The PCB itself contains analog buffers, 
programmable low noise voltage supplies, and a current-sensing circuit. The analog buffers are integrated 
to further buffer the eight analog outputs from the array before they are routed to the analog to digital 
converter (ADC) of the DAQ card. The low noise voltage supplies for the IC provide the chip with power 
signals, Vdd and Vss, and reference voltages used in the amplifier design. The chip ground, Vss, is digitally 
programmable from -5.0 V to +5.0 V with 1 mV accuracy with respect to solution’s reference electrode 
biased at earth ground; Vdd (fixed +5.0 V to Vss ) and the reference voltages (digitally programmable with 
0.5 mV accuracy) are then referenced to Vss. As a result, the stimulation buffer at the pixel is able to 
achieve both positive and negative voltage stimulation with respect to the reference electrode. This 
configuration also ensures that all source/drain-to-body diodes of the CMOS transistors connected to the 
nanowires remain reversed biased and unconducting. To measure the current through the reference 
electrode immersed in the solution, a digitally programmable inline current sensing circuit is used with 
four current sensitivities (0.1 nA/V, 1 nA/V, 10 nA/V, and 100 nA/V) and read by the DAQ’s ADC, 
allowing for positive and negative current measurements from ~1 pA to 1 µA. All circuitry on the PCB 
and IC are programmed and read through the DAQ card and interfaced by the user through a real-time 
custom Labview software, along with the microscope, manipulators, and camera. 
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Figure 4.7 | Block diagram of the overall system depicting the operation of the CNEA using the printed 
circuit board (PCB), data acquisition (DAQ) card, and personal computer (PC). 
 
 
Device characterization 
Standard electrical measurements on chips that did not undergo post-processing facilitated the 
characterization of the pixel circuitry electrical performance. Initially, characterization of the amplifier for 
recording electrophysiological signals allowed the evaluation of the two distinct designs of the first stage 
amplifier (LNA); the first design located on the chip’s top half has a measured passband voltage gain of 
~20 V/V by design while the bottom half design ~8 V/V. Changing the parasitic junction capacitance of 
the diode pairs used as pseudo-resistors attains the passband gain difference between the two amplifier 
designs. The higher gain of the amplifiers in the top half pixels is attained via the lower parasitic 
capacitance associated with the larger number but smaller diodes in series, in comparison to the design of 
the bottom pixels. The measured transfer functions of the top (red) and bottom (blue) pixel overall 
amplifiers from Vin to Vout, shown in Figure 4.8a, convey the overall passband gain of ~400 V/V for the 
top pixel and ~180 V/V for the bottom pixel. Moreover, the measured transfer functions show the 
bandwidth of the bandpass configurations that filter out the low-frequency 1/f noise and high-frequency 
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noise above 5 kHz; the top passband gain of ~400 V/V is accompanied by a bandwidth of 0.05 Hz to 5 
kHz while the bottom passband gain of ~180 V/V is accompanied by a bandwidth of 0.1 Hz to 5 kHz. In 
addition, measurements of the amplifier gain as a function of the VGA setting (Fig. 4.8 b), which once 
again shows the difference in passband gains of the two distinct designs in addition to conveying the 
availability of a wide range of gains that maximize output dynamic signal range. Measurements of the 
maximum amplifier gain across the whole array, shown in a 32x32 heat map array (Fig. 4.8 d), was 
obtained by turning on both the stimulators and amplifiers of the entire array and applying a sine wave (1 
mV, 100 Hz) to the stimulators and recording the amplifiers’ outputs. 
 
Figure 4.8 | (a) Measured transfer function of the top and bottom pixel overall amplifiers. Typical 
bandwidth of electrophysiological signals, in particular, membrane oscillations (MO), postsynaptic 
potentials (PSP), and action potentials (AP), are shown. (b) Measured amplifier gain as a function of the 
VGA code, Gain[1:4], for both the top and bottom pixels. (c) Output power spectral density (PSD) of a 
bottom pixel with typical electrophysiological bandwidths shown. (d-e) Heat map plots of all 32×32 
pixels in the array of an integrated circuit showing the (d) maximum amplifier gain at 100 Hz. and (d) 
estimated integrated input referred noise across the electrophysiological bandwidth from 1 Hz to half the 
sample frequency, 4.875 kHz. (f) Linear distribution of input referred noise (e) (two outliers above 
3 mVrms omitted). 
 
Afterwards, noise characterization was performed through measurements of the output power 
spectral density (PSD) of a bottom pixel with typical electrophysiological bandwidths (1 Hz to 5 kHz), as 
shown in Figure 4.8 c. At maximum gain the integrated output noise of this particular pixel resulted in 
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38.4 mVrms. The integrated input referred noise at Vin – referring to nanowire voltage node – is calculated 
by using the pixel’s maximum passband gain of 152 V/V turns to be 253 µVrms. Similarly, measurements 
of the output noise were performed across the whole array and the integrated input referred noise was 
calculated (integrated output noise divided by the pixel gain) across the electrophysiological bandwidth 
from 1 Hz to 5 kHz; it resulted in ~250 µVrms as shown in the heat map in Figure 4.8 e. A difference in 
input referred noise is also seen between the top and bottom half pixels since more noise is filtered in by 
the larger bandwidth of the top design.  
Characterization of the whole pixel array allowed the overall evaluation across the chip; it further 
portrayed the difference in gain of the top and bottom amplifier design, identified some performance 
variability from site to site despite their identical design, and allowed the measurement of maximum 
power density. The significantly larger gain associated with the top pixel design in comparison to the 
bottom pixel design is clearly depicted in the heat map in Figure 4.8 d. In addition, this heat map clearly 
portrays the gain variability from site to site, more significant in the top pixel design. This gain variability 
is mainly attributed to process variation of the feedback diode-pair parasitic capacitance; hence the top 
half with more diodes pairs has more variability. Furthermore, these large-scale measurement allowed the 
characterization of the maximum power density that resulted to be 61.5 mW/cm2, measured with all 
amplifiers turned on and in good agreement to the designed value and fitting for substrates supporting 
viable cellular cultures.  
Post-fabricated chips are further evaluated by characterizing the top nanowire to solution 
interface. The nanowire conductance was characterized through current-voltage (I-V) measurements 
between individual pixels and the Ag/AgCl reference electrode in extracellular solution. Figure 4.9 a 
shows the I-V characteristics in extracellular solution of two distinct nanowire electrodes, one consisting 
of an exposed gold tip and the other one platinum. The plots show linear voltage ramps at a scan speed of 
50 mV/s across a range of 2.5 V centered near the I = 0 point (~0.3 V vs. Ag/AgCl for Pt and ~0.45 V vs. 
Ag/AgCl for Au). The data shows that there is a wide range of purely capacitive interaction via the double 
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layer capacitance, the region in which the reading amplifier operates. Beyond this region, both positive 
and negative faradic currents flow.  
 
Figure 4.9 | (a) Current-voltage measurements of two pixels, Pt and Au tipped, vs. a Ag/AgCl reference 
electrode in extracellular solution. A linear voltage ramp is applied at a scan speed of 50 mV/s across a 
range of 2.5 V centered near the I = 0 point (~0.3 V vs. Ag/AgCl for Pt and ~0.45 V vs. Ag/AgCl for Au). 
(b) Measured nanowire current of each pixel across two devices, Pt and Au, with the application of a 
voltage step of 1.5 V vs. the Ag/AgCl reference in extracellular solution. The current is measured 100 ms 
after the voltage step. 
 
Across the chip, evaluation of the nanowire conductance is obtained through the generation of 
conductance maps (Fig. 4.9 b), which is run before each electrophysiological test to ensure that 
conductive nanowires are present, and to track changes through multiple device use. This characterization 
is performed by measuring in a sequential order (one pixel at a time) the current through the reference 
electrode after 100 ms of applying a 1.5 V signal through the pixel’s stimulation buffer. The 100 ms 
pause is helpful to ensure faradic current, and therefore exposed metal tips, as opposed to purely 
capacitive current through the insulating silicon dioxide on the nanowire sidewalls and pad. Pixels with 
currents measuring less than ~30 pA (dark blue in plots of Fig. 4.9 and 10), an empirically determined 
value, are considered to be non-conductive to perform experiments. Overall analyzes of the measured 
conductance show more than ~90% of the sites to be functional in stimulation and recording experiments.  
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Figure 4.10 | Nanowire conductance across 6 different chips while in extracellular solution. A 1.5 V 
voltage step is applied to each pad with respect to the Ag/AgCl reference electrode and the current is 
measured after 100 ms. The three on top are Platinum tipped nanowires and the three on the bottom are 
Gold tipped nanowires. 
 
 
4.5 Interfacing Biological Systems 
We characterized the CNEA interface with cellular cultures and optimized its operation protocols 
using HEK293 cells as a model system. HEK293 cells offer an ideal platform since they have a short 
culture time (only a few hours) before electrical interrogation, and their membrane resistance has a robust 
passive electrical response remaining constant within 15mV of the resting membrane potential116. We 
performed simultaneous interrogation of HEK293 cells residing directly on top of the nanowires via (1) 
whole-cell patch-clamp stimulation/recordings and (2) voltage readings through the nanowires and their 
local amplifier to evaluate the overall functionality of the nanowire electrode pixels. Patch clamp is used 
in these experiments for verification and characterization of the nanowire performance. 
We begin standard experiments by evaluating and characterizing the complete 32x32 array by 
measuring the gain and deriving the input referred noise. Figure 4.11 a,b show the heat maps of these two 
parameters, correspondingly. Subsequently, we proceed with the identification of centrally localized cells 
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on top of pixels with suitable characteristics and start the biological experiments. Typically, we use a 
short voltage pulse to permeabilize the cell membrane and promote nanowire penetration, thus resulting 
in intracellular electrical coupling26,127,140. Operating the patch clamp in voltage clamp mode allowed 
monitoring of the cellular current response simultaneously with voltage pulse stimulations (Fig. 4.11d, 
bottom row). Without spontaneous membrane permeabilization, nanowire electrodes cannot detect 
changes of the membrane potential resulting from applied patch pipette voltage pulses (Fig. 4.11b, first 
column, NW – top, patch clamp – bottom). However, application of a voltage pulse through the 
nanowires (Fig. 4.11d, middle column) induces intracellular electrical coupling, thus allowing high-
fidelity nanowire measurements of the stimulated membrane potential changes (Fig 11d, third column, 
top row).  
 
Figure 4.11 | (a) Heat map of pixel gain across the 32x32 array; clearly depicting the difference between 
the top and the bottom pixel designs. In addition, the pixel gain value determines the bias voltage to be 
applied to the pixel enabling the operation of the amplifier in its optimal range. (b) Input referred noise 
estimated by integrating the output power spectral density over the signal frequency range and dividing 
the measured gain generated through automatic current mapping to determine pads with good NWs. 
Apply 0.5V for 200ms on each pad, read corresponding current. (c) Representative DIC micrograph of 
HEK293 cells cultured on a CNEA device; patched cell centrally located on pad BO. (d) Simultaneous 
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Figure 4.11 (Continued). recording on HEK cell from nanoelectrode (top raw) and patch clamp (bottom 
raw) in response to patch voltage pulses. 
 
Once intracellular access is achieved, we use the nanowire electrodes to monitor the membrane 
potential with high fidelity and resolution. To characterize the recording capabilities of CNEA pads, we 
used the patch pipette to change the membrane potential by applying voltage signals to the cell (in voltage 
clamp mode) and measure them simultaneously with the nanoelectrodes. Specifically, the change in Vm 
induced by the patch pipette led to a change in the nanowire voltage due to the charging/discharging of 
the electrical double layer at the metal-coated nanowire tips. Figure 4.12a below shows the nanowire 
voltage measurements in response to patch pipette pulses, 20 mV and 50 mV, across several pads/cells. 
These particular measurements were performed with the top design pads, which are characterized by 
higher gain compared to the bottom design pads (Fig. 4.11a). In addition, we conducted long duration 
recordings through the nanowires on HEK293 cells of sequential voltage pulses with increasing 
magnitude applied via the pipette, (Fig. 4.12b). As depicted in the heat map across the array of the 
amplifiers’ gain and observed in these recordings, there is a significant variability in the measured 
magnitude of the output signal resulting from the range of gains from ~13 V/V to ~ 26 V/V. Furthermore, 
the long-term measurements of the membrane potential through the high-gain, top amplifiers show 
saturation at the baseline (~ 0.2 V) 	  due to the reference voltage not centering the amplifier’s DC output in 
the middle of its dynamic range, (0.2 V to 2.6 V) in combination with a large gain of the amplifier,  Fig. 
4.12b. These variation studies allowed further evaluation of pixel performance.  
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Figure 4.12 | Recording of voltage pulses with different magnitude and on different cell. (a) 
Nanowire measurements of changes in membrane potential of HEK293T cells in response to applied 
patch pipette voltage pulses of 50 mV (left) and 20 mV (right). (b) Current response of the cell measured 
simultaneously via a patch pipette.   
 
In addition, we utilized similar HEK293 experiments to characterize the stimulation/recording 
performance of the bottom pads and evaluate the differences between the top and bottom amplifier 
designs. Similar to the top pads, once the nanowire-cell interface is intracellular, the changes in the 
membrane potential with increasing amplitude (induced via the patch clamp in voltage clamp mode) are 
recorded reliably through the nanowires and pixel amplifier. As expected from the amplifier design, these 
measurements are characterized by significantly lower intergraded gain of ~5 V/V. This reduced gain is 
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as expected based on the circuitry design that defined the maximum passband gain of the amplifier to be 
400 V/V for the top circuitry while 150 V/V for the bottom circuitry. On the positive side, the lower high-
f and low-f noises associated with the bottom circuitry facilitates measurements of the membrane 
potential without saturation and better SNR. Analysis of the recordings of Fig. 4.13c showed that voltage 
changes measured at the nanowires were ~ 50 times smaller than the voltage changes controlled by the 
patch clamp. These capacitively coupled measurements through the on-pixel amplifier demonstrate a 6x 
improvement in comparison to our VNEA measurements performed via off-chip amplifiers. Furthermore, 
we evaluated the recordings of typical neuronal signals (using actual action potentials measured through 
patch clamp from in vitro cortical neurons) applied to HEK293 cell. AP-like signals are clearly 
distinguishable from the noise in single measurements (measured input referred noise, 230 µVrms). 
Besides verifying the capability to measure neuronal signals, these measurements show that the nanowires 
are measuring intracellular signals with minimal signal distortion. This is observed in the averaged output 
data that fully preserve the original waveform (Fig. 4.13c).  
Once the nanowires had access to the interior of the cell, the pixel was also used to 
control/stimulate the cell’s membrane potential. As an example, Fig. 4.13 d shows the changes in 
membrane potential measured at the patch pipette resulting from the applied biphasic voltage pulses 
through the nanowires. The changes in the membrane potential are tracked through the patch pipette in 
current-clamp mode by monitoring the potential value required to maintain the fixed current. Since the 
biphasic voltage pulses are centered near I = 0 A (the plateau region of the current-voltage curve of the 
nanowires) the stimulating pulse is transmitted primarily through the double layer capacitance of the 
nanowire interface, thus resulting in the RC response of the changes in membrane potential. Nevertheless, 
we show that biphasic pulses (~ 1 V) can manipulate the membrane potential by more than ±50 mV, 
corresponding to a large enough amplitude to stimulate and/or inhibit action potentials. These 
characterizing and evaluative experiments on HEK293 cells demonstrate the two-way and intracellular 
interface with the capability of stimulation and recordings of real-time neuronal activity.  
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Figure 4.13 | (a) Microscope image of HEK293 cells sitting on top of a pixel pad with nanowires 
simultaneously interfaced via a patch pipette. (b) Voltage signals are applied to the patch in voltage clamp 
mode and measured through the nanowires and pixel amplifier to characterize the ability of the CMOS-
nanowire array chip in measuring cellular signals. (c) Measured input, Vpatch, and output, Vamp, signals 
from the HEK293. Increasing voltage pulse amplitudes (left) and recorded action potential shaped signals 
from in vitro rat cortical neurons (right) are measured through the nanowires; 50 pulse sequences and 100 
action potential sequences are averaged for Vamp,avg to reduce the noise. (d) Applied biphasic voltage 
pulses to the nanowire, Vnw, and measured responses of the HEK293 cell’s membrane voltage, Vpatch, (left) 
using the patch pipette in current clamp mode (right). The applied signal to the nanowire is approximately 
centered at the I = 0 point.  
 
Cardiomyocytes – long term and stable recordings/ interface 
Next, we made use of cardiomyocytes to further investigate and evaluate the capability of CNEA 
devices in recording intracellular signals. We cultured neonatal rat ventricular cardiomyocytes that 
typically fire action potentials spontaneously, resulting in beatings that are simultaneously observed with 
	  73	  
	  
our optical microscope, thus eliminating the necessity of patch clamping as a second independent probe. 
To use the CNEA with cardiomyocyte cultures, we coated them with nitrocellulose and allowed the 
cultures to grow and develop for between five and seven days. Right before experiments, we evaluate the 
culture’s viability and perfuse it with Tyrode solution (extracellular solution mimicking biological 
conditions) to facilitate the electrophysiological study of cardiomyocytes.  
In addition, before starting biological measurements we assess and adjust several controllable 
parameters of CNEAs to optimize their performance. Based on previous studies, we determined that 
biasing the Vss to -2.7 V minimizes the leakage currents resulting from the amplifier diodes. Also, we set 
the bias voltage (Vbias) of individual pads based on their specific characteritics, which is determined 
through automatic generation of a bias voltage-gain sweep map. The bias voltage is swept from high to 
low with the gain and output voltages measured at each Vbias,. The bias voltage which places the 
amplifier’s output in the center of its dynamic range is then chosen, thus resolving the variation of 
optimal performance across the array. Subsequently, we perform automatic current mapping (by applying 
0.5V for 200ms on each pad and reading the corresponding current) to determine pads with good 
nanoelectrodes and eliminate the usage of non-conductive nanoelectrodes, which is typically only 10%.   
Once the CNEA functional settings are optimized, we identify the pads that are directly 
interfacing actively beating cardiomyocytes via the central nanoelectrodes. First, we monitor the amplifier 
recordings to determine whether electrical coupling is achieved naturally. To determine the coupling 
status, we utilize cells beating spontaneously, monitored via microscope, which coincide with their 
membrane potential changes (APs). If we can’t detect their electrical activity via the nanowire recordings, 
the pad is switched to stimulation mode to facilitate membrane permeabilization leading to intracellular 
access. In stimulation mode, we set Vbias at 2 V in the middle of the stimulation range (0 – 4 V) while Vss 
is set at -2.7 V, which corresponds to setting the NW in the center of its capacitive range, thus eliminating 
any current passage. A typical membrane permeabilization protocol consists of three trains of pulses 0.5 s 
spaced apart with each train consisting of five 50 Hz biphasic pulses. The peak-to-peak magnitude of the 
stimulation pulses start at 1 V and gradually increase with 0.1 V increments until we can record the 
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beating. Concurrent mechanical beating of the cell can often be observed with stimulation pulses, and can 
be used as a sign to confirm that we have electrical coupling. Having achieved intracellular access, we 
switch to recording mode and monitor the continuous cardiomyocyte AP trace.  
Results of a typical experiment are summarized in Fig. 4.14. Initially, it shows a trace depicting 
the continuous movement of an electrically active cardiomyocyte cell (top), calculated through taking 
derivative of image acquisition. The trace peaks are directly correlated to the beat of the cell as indicated 
by the aligned action potential spikes (shown in the middle row) recorded through the underlying 
nanowire by the amplifier. Some of the spikes recorded by the amplifier were not observed in the cell 
movement, which is due to the low frame rate of image acquisition. The bottom row of Fig. 4.14 shows 
detail of recorded action potentials with good signal-to-noise ratio (left) and a recorded action potential 
that shows sub-threshold behavior, with the membrane rising before it fired an action potential (right). 
These recordings clearly demonstrated the ability of our nanoelectrodes and the underlying integrated 
circuitry to record electrical signals from cardiomyocytes with high fidelity and resolution.       
 
Figure 4.14 | Recordings of cardiomyocyte electrical activity. 
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We also utilized our nanoelectrodes to stimulate cellular action potentials by applying voltage 
pulses VNW while operating the underlying circuitry in stimulation mode. Fig. 4.15 shows cell movement 
(top), with peaks correlated to the beat of the cell. Initially, the cardiomyocyte was beating at a relatively 
low frequency, about once every 30 seconds. To achieve a higher frequency activity (a proper beating 
activity of around 1 beat/sec corresponding to a normal heart rate), 10 trains of pulses were then applied 
at a frequency of about one pulse per second (bottom) to the nanowires interfacing the cardiomyocyte. 
We used pulse-trains consisting of five 50Hz biphasic pulses with peak-to-peak voltage 2 V, with the 
spacing between them set to 1 sec. Upon application of the pulses, the cardiomyocyte fired action 
potentials at a frequency corresponding to the applied pulses, thus demonstrating the ability of the 
nanowire to intracellularly stimulate a cardiomyocyte.       
 
Figure 4.15 | Stimulation of cardiomyocyte electrical activity. 
Monitoring neuronal activity of in vitro hippocampal and cortical neuron culture 
Having completed the device characterization and protocol optimization, we used the CNEA to 
interrogate rat cortical neurons through high-fidelity intracellular recording and stimulation of their 
electrical activity. Optimal conditions for neuronal cultures were achieved by optimizing the surface 
treatment of CNEA devices through a two-day process that generated the poly-d-lysine culture support 
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coating. To allow electrophysiological development and the formation of synaptic connections, we 
cultured the cortical neurons for a minimum of 6 days in vitro before interrogation. Initially, we used 
nanoelectrodes to monitor changes in the membrane potential in response to sequential pulses of 
increasing amplitude applied via a patch pipette in the voltage clamp mode (1. 7b). Single-shot data, 
shown on the top in Fig. 4.16b, are typically characterized by 2~3 signal-to-noise ratio, while the average 
of 50 sequences obtained under identical experimental conditions could improve the signal-to-noise ratio 
by an ideal factor of sqrt(# of averaged samples) or ~7× improvement to 14~21. Furthermore, we utilized 
the nanoelectrodes to monitor individual action potentials (APs) evoked by a patch pipette. In this 
experiment, we ran the patch clamp in current clamp mode to inject current pulses that induced the neuron 
to fire APs. This particular dataset is associated with a lower SNR ratio due to the higher attenuation at 
the nanowire-cell interface (100x compared to the ~ 25x of the previous dataset). As before, averaging 
(100) sequential pulses obtained under identical experimental conditions, we could recover the AP 
waveform pattern in close correlation with the patch clamp measured potential. As demonstrated in Fig. 
4.16e, we achieved stimulation of neuronal activity by applying biphasic voltage pulses to the 
nanoelectrodes. The active response to the third pulse (shown in Fig. 4.16f zoomed in view, bottom left) 
is distinguished by larger amplitude and specific shape that characterize typical APs. Aiming to minimize 
the number of pulses necessary to evoke individual APs, we established that by applying two biphasic 
pulses the neuron fired on the second pulse.  
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Figure 4.16 | Recordings and stimulations of neuronal activity. (a) Micrograph of a centrally located 
cortical rat neuron, interfacing the nanoelectrodes through cell body. (b) Schematic of the dual cell 
interface during NW recordings: Voltage signals are applied to the patch in current clamp mode and 
measured through the nanowires and pixel amplifier to characterize the ability of the CMOS-nanowire 
array chip in measuring cellular signals. (c) Schematic of the dual cell interface during NW recordings in 
current clamp mode: Current pulses are injected to cause the neuron to fire an action potential which are 
then read through the nanowires. (d) Membrane potential changes measured via the NWs, Vamp, in 
response to a patch pipette pulse sequence of increasing amplitude, Vpatch. The average of 50 sequences 
shown to reduce the noise, with one-shot data shown in the inset. Current response measured through the 
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Figure 4.16 (Continued). patch pipette, shown in the middle, shows the cell viability even after 
penetration for intracellular recordings. (e) NW recording of neuron action potential fired in response to 
current pulses injected through the patch pipette; single shot NW data (top, red), averaged NW (middle, 
blue), and patch pipette simultaneous recordings (bottom, magenta). (f) Neuron fires action potentials 
stimulated via biphasic voltage pulses applied to the nanowires. (g) Schematic of the dual cell interface 
during NW stimulations: using the patch pipette in current clamp mode while applying voltage pulses 
through the NWs.  
 
 
4.6 Prospects 
Generation of tissue interfaces 
The results presented here establish the CNEA platform to be capable of intracellular and parallel 
recording/stimulation of in vitro neuronal ensembles. For ex vivo applications of the AP chip for slice 
recording, we will fabricate long electrodes with sharp tips (>25 µm in length, 150-nm diameter at the tip, 
and 1.5-µm diameter at the base) so that we can penetrate through a layer of dead cells and access live 
neurons deep within the tissue (Fig. 4.17). We have developed the process flow for the fabrication for ex 
vivo devices as summarized in Figure 4.17. First, we flip-chip bond a silicon-on-insulator (SOI) substrate 
on the CMOS chip via conductive gold bumps, and fabricate the electrodes out of the SOI substrate. To 
this end, we will use reactive ion etching on the handle layer to expose the buried oxide layer of the SOI 
substrate. We will then generate an array of 1.5-µm diameter photoresist discs (serving as etch masks at 
the later step) on top of the buried oxide. Two subsequent steps of reactive ion etching applied to of the 
buried oxide and silicon device layer will generate the long electrodes on top of the exposed CMOS metal 
contacts. Subsequently, we will use dilute buffered oxide etch to selectively thin the 3-µm-tall oxide tip to 
150 nm while leaving rest of the silicon base (1.5 µm in diameter; 25 µm in length) intact. The thicker 
base provides structural rigidity required for tissue penetration. Last, we will perform metallization and 
passivation via similar processes developed for the in vivo platform generation. This advanced geometry 
of the front side of the array will enable interfacing and studying intact slices of brain tissue.  
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Figure 4.17 | (a) Summarized process-flow for generating tissue-interfacing nanoelectrodes. (b) SEM 
images of the two level nanoelectrodes fabricated through our optimized processes.  
 
Network level studies – Functional map generation 
The unique combination of intracellular and parallel features characterizing our nano-neuro 
interface, pave the way for higher-level experiments to map the functional connectivity of neuronal 
networks both in vitro and ex vivo. We are particularly interested in addressing the question of how 
changes to the input-output relationships of neuronal networks form the foundation of learning and 
memory141. The mechanisms and dynamics of this process remain poorly understood due to a lack of tools 
that are capable of simultaneously recording and stimulating the electrical activity of many individual 
cells142. 
The CNEA can overcome these limitations because it enables simultaneous intracellular 
measurements from many cells within a single circuit. Using this approach, we will search for trends in 
the spatiotemporal dynamics of neuronal networks as they are trained to perform specific computations. 
By identifying characteristic network dynamics that frequently occur during the training process, we will 
develop functional network motifs that will guide future studies of network dynamics ex vivo and in vivo, 
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and help in developing theories for learning and memory behavior. The concept of structural network 
motifs – frequently repeated connectivity sub-graphs that appear within a larger network – has proven to 
provide a powerful technique for analyzing networks and decomposing them into functional building 
blocks143. Using our CNEA we will search for functional equivalents of these structural motifs, referred to 
as functional motifs, and use them as building blocks for analyzing complex network dynamics (Fig. 
4.18). The identification of these functional motifs will start by training many in vitro networks to 
perform simple computations144,145. Using our CNEAs combined with long-term fluorescence 
microscopy, we will then monitor the functional and structural connectivity of the network as it responds 
to controlled electrical and chemical inputs. To efficiently train the network and achieve a desired input-
output relationship, we will compare a variety of input protocols including tetanic stimulation146, paired 
stimulation protocols147, and	   chemical reward148. Stimuli will be delivered to the network either 
electrically (using the CNEA) or optically (by transfecting a subset of the cells with light gated ion 
channels50 and illuminating the network with specific spatial excitation patterns). The functional 
connectivity of a network will be represented as a point in multi-dimensional space where each coordinate 
stands for the strength of a possible synaptic connection. Changes to the synaptic strengths will move this 
point through the multi-dimensional connectivity space creating a trajectory. By repeating the stimulation 
protocols on many different neuronal preparations, we should be able to identify frequently occurring 
trajectories, or functional network motifs, that can serve as templates for investigation of in vivo neuronal 
dynamics and be used to develop learning rules that recapitulate the observed motifs.	  These investigations 
will guide future studies of network dynamics ex vivo and in vivo, and test theories of learning and 
memory behavior. 
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Figure 4.18 | Optical/electrical stimulation and recording of neuronal network activity in vitro will be 
combined with optical imaging to identify repeated patters of structural connectivity and functional 
activity. Lower panel: the synaptic strength of each connected pair monitored as a function of time 
(represented as a matrix of synaptic weights W). Upper right: example network (structural and 
functional/dynamical) motifs. 
 
 
High-Throughput Discovery and Pharmaceutical Screening 
To date, many neurological disorders remain poorly understood and lack therapeutic treatments; 
despite greater than ever research programs focusing on elucidating the cellular basis and screening for 
potential new drugs. In part, this has been attributed to a shortage of drug screening assays that facilitate 
large-scale experiments with primary mammalian neurons149. Our CNEA platform, with its capability for 
(1) intracellular recording/stimulation of neuronal activity with the fidelity that matches patch clamp 
pipettes and (2) high-throughput, massively parallel measurements of the responses of connected neuronal 
pairs and networks upon well-defined electrical and chemical stimulations (a task that would be 
prohibitively laborious using the currently available methods), is well suited for this task. Coupling the 
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CNEA to microfluidics – to enable rapid perfusion of pharmacological compounds in conjunction with 
electrophysiological testing – would facilitate the characterization and categorization of the behaviors of 
diseased mammalian neurons under the influence of small molecule pharmaceutical candidates. These 
capabilities make the CNEA platform an optimal assay for screening novel ion channel drug candidates in 
addition to helping elucidate the electrophysiological characteristics cellular mechanism of the 
corresponding neurological disorders, overall experimental schematic shown in Fig 20.   
Genome-wide association studies continue to identify ion channel mutations that result in their 
irregulated activity leading to many debilitating diseases, including Parkinson’s, Alzheimer’s, 
hyperactivity disorders, epilepsy, and autism149-151. Neuronal nicotinic acetylcholine receptors (nAchRs) 
are one such example. nAchRs are cholinergic receptors that represent a superfamily of ligand-gated ion 
channel, and are pentameric complexes comprising different combinations of alpha (α2 – α10) and beta 
(β3, β4, β5) subunits.  These receptors are emerging as potential drug targets for a variety of neurological 
diseases including Parkinson’s disease (PD), Morbus Alzheimer, and hyperactivity disorders149. Some of 
nAchR subtypes (e.g. α4β2*, α6β2*, α4β2β3, and α4α6β2β3) are involved in the signaling pathways that 
are affected in Parkinson’s disease152, and thus can serve as particularly relevant therapeutic targets for 
the disease. Despite the increased interest in their potential as druggable targets they remain underutilized, 
and their physiology as well as involvement in neuronal pathologies remains poorly understood153. It 
remains unclear whether nAchR ligands exert their beneficial effects via receptor activation or blockage, 
leaving unresolved the question whether agonist or antagonist ligands would prove most beneficial for the 
treatment of PD symptoms152,153. 
Previous studies have identified some signature electrophysiological characteristics associated 
with the different nAchR subtypes. Utilizing the CNEA capabilities, we will first expand upon these 
findings towards a comprehensive identification and classification of the nAchR subtypes affected in PD 
and their corresponding phenotype. Several mouse models that recapitulate the symptoms and 
pathological features of Parkinson’s disease have been validated. The initial experiments will therefore be 
conducted using neurons extracted from these Parkinsonian mouse models. We will focus our initial 
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efforts towards the discovery of therapeutic compounds targeted at α4β2* and α6β2*, previously 
identified as potential sites of drug action. Afterward, we will extend our drug discovery efforts to other 
subtypes. The efficacy of therapeutic compounds will be screened by profiling the compounds’ effects on 
nAchR-mediated currents, in particular, on the modulation of the peak and steady-state currents as a 
function of drug concentration and treatment protocol. This electrophysiological measurement will be 
combined with dopamine concentration assays as well since dopamine is an essential component of the 
circuit involved in PD. A better understanding of the different nAchR subtypes and their mechanism of 
action will enable the design of more specific and efficient therapeutics for Parkinson’s disease. 
 
Figure 4.19 | Leveraging the high-throughput, high fidelity electrophysiology capability of our CNEA to 
perform screening of novel therapeutic compounds for neurological diseases; focusing on neuronal 
cultures and slice preparations extracted from the mouse models of Parkinson’s disease. The same 
strategy should be applicable to neurons induced from human patients as well. 
 
Another major line of research in drug discovery efforts for PD is focused on targeting pre- and 
postsynaptic sites in dopaminergic neurons. The impairments in synaptic plasticity, such as long-term 
potentiation (LTP) and long-term depression (LTD), have been widely implicated for the onset and 
progression of PD. For instance, alterations in the subunit composition of N-methyl-Daspartate (NMDA) 
receptors, which impair synaptic plasticity, are known to contribute to the pathological characteristics of 
PD154-156. Consequently, significant efforts have been made to identify molecules that can rescue normal 
synaptic activity in Parkinsonian mouse models. However, these efforts have been hampered by the low-
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throughput of whole-cell patch clamp experiments. Our CNEA device, being able to simultaneously 
stimulate and record the activity of multiple connected neurons in dissociated cultures, will facilitate the 
ability to study and characterize these synaptic pathways in a much higher throughput, thereby expediting 
the discovery of potential drug targets as well as novel therapeutic compounds. The change in synaptic 
efficacy can be characterized by studying the change in amplitude as well as in the rising slope of PSPs. 
We will focus our initial screening efforts on therapeutic compounds targeting NMDA receptors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  85	  
	  
 
 
 
 
 
 
 
APPENDIX A 
 
Vertical Nanowire Electrode Arrays for Stimulating and 
Measuring the Activities of Multiple Mammalian Neurons 
 
A.1 Introduction 
Intracellular electrodes based on patch pipettes, which control and measure the membrane 
potential via direct electrical coupling, remain the most accurate technique for stimulating and 
recording neuronal activity. Unfortunately, due to the bulkiness of micromanipulators as well as 
the challenge of forming and maintaining high-quality cell-pipette interfaces60,64,112, most patch-
clamp studies have been limited to the simultaneous measurements of only a few neurons. 
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Efforts to parallelize this technique via planar patch-clamp chips have not yet been optimized for 
mammalian neurons, primarily due to difficulties in forming seals to their small neuronal cell 
bodies64-66,67,68. For large-scale interrogation of neuronal networks, microelectrode arrays 
(MEAs) are the tool of choice because they can monitor the neuronal activity from many neurons 
simultaneously. However, MEA measurements are extracellular and consequently, do not 
provide adequate signal-to-noise ratios to resolve subthreshold events114. Moreover, because a 
single electrode can stimulate or sense the activities of several neighboring cells, MEAs lack 
precise cell-to-electrode registry114. 
To address some of these issues and pave the way for large-scale neuronal network 
studies, semiconductor nanofabrication-based approaches, have been employed to generate a 
new class of electrical interfaces to neurons and other electroactive cells11,71,72,75-77,109-
111,113,157,158. These tools, reviewed in detail elsewhere114,158,159, rely on nano- and microscale 
structures that provide a minimally invasive interface to the cell’s interior. For example, gold 
mushroom-shaped microelectrodes can perform multisite ‘intracellular-like’ recording and 
stimulation of neuronal activity in Aplysia neurons and primary rat cardiomyocytes75,77. 
Similarly, nanoscale structures based on field-effect transistors (FET) or vertical platinum 
nanowires enable true intracellular recording of action potentials in cardiomyocytes10,11,72,73. 
Each of these methods utilizes nanofabrication approaches to create recording platforms that can 
be scaled up to interrogate many cells simultaneously without using micromanipulators. A 
logical next step, then, is a nanofabricated device specifically designed and optimized to 
stimulate and record the activities of primary mammalian neurons. 
Recently, we reported vertical nanowire electrode arrays (VNEAs) as a scalable 
experimental platform for performing parallel intracellular stimulation and measurement of 
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mammalian neurons127. These devices are fabricated from a silicon-on-insulator (SOI) wafer 
using standard nanofabrication processes and consist of an array of stimulation/recording pads. 
The first prototype had 16 pads, each of which contained a set of 9 vertical nanowires (Fig. A.1a-
e); however, the number of pads and nanowires per pad can be varied to match experimental 
need. The VNE prototype design (nanowire diameter: 150 nm, length: 3 µm, pitch: 2 µm) was 
optimized to facilitate intracellular penetration and interfacing to individual neurons. The 
nanowire tips are selectively metalized to form the intracellular electrical interface, while the 
insulating glass sidewalls serve the dual function of forming a tight seal with the cellular 
membrane and preventing current leakage. Each electrode pad is individually addressable via a 
silicon track ending at a metal contact pad connected to control electronics. A 
polydimethylsiloxane (PDMS) well, shown in Fig. A.1e, supports dissociated neuronal culture 
directly on top of the VNEA. Individual devices are reusable over an extended period of time (> 
1 year), provided that care is taken to clean and store them as described in this protocol. 
 
Figure A.1 | Device Layout. a, Schematic of a prototype device showing highly doped silicon 
electrode tracks (blue), exposed buried oxide layer (BOx) (grey), metal contact pads (orange, 
numbered 1-16), and substrate pads (S1, S2). Scale bar, 4 mm. b, Schematic of the sixteen 
electrode pads arranged in a 4 × 4 array with a 200-µm pitch. The central light-blue region 
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Figure A.1 (Continued). represents thinner (20 nm) SiO2 insulation around the silicon nanowires. 
Scale bar, 200 µm. c, Schematic of a VNEA pad showing the 3 × 3 array of vertical nanowires. 
Scale bar, 5 µm. d, Three-dimensional rendering of the VNE cross-section (corresponding to the 
dashed region in c) showing the sputter coated metal tips (orange) and thin (20 nm) SiO2 sidewall 
insulation (grey) surrounding the silicon nanowire core (blue). A thick (150 nm) Al2O3 insulation 
(dark-blue) covers the electrode tracks and regions of the exposed BOx (not drawn to scale). e, 
Image of a prototype VNEA device (25 × 25 mm) consisting of 16 stimulation/recording pads 
and a PDMS washer (12 × 25 mm). The PDMS washer contains a central double well (generated 
using two 3 mm-diameter biopsy punches) surrounding the active region of the device and two 
additional wells holding neurons for media conditioning (generated using a 6 mm-diameter 
biopsy punch). Scale bar, 5 mm. 
 
The parallelized stimulation and recording capabilities of the VNEA can be used to map 
multiple individual synaptic connections in an in vitro neuronal network127. Additionally, the 
VNEA allows for straightforward coupling with conventional patch clamping60,160,161, 
fluorescence microscopy, and optogenetic techniques50, making possible multiplexed circuit-
level studies. For example, a projector coupled to an upright microscope can be used to define a 
stimulation pattern for a neuronal culture expressing light-gated ion channels162 (e.g. 
channelrhodopsin and halorhodopsin). The VNEA platform can then be used to record the 
activities of multiple neurons in the circuit and monitor how neuronal activities change both over 
time and in response to well-defined stimuli. The same platform can also be used to examine 
altered electrophysiological and synaptic activities in disease-affected neurons, as well as the 
responses of those cells upon the application of pharmaceutical candidates154,163,164. To date, 
most of these screening efforts have relied on patch-clamp measurements, which suffer from 
limited throughput11; the use of VNEAs for this purpose will facilitate the rapid characterization 
of disease-related synaptic connections and the discovery of new drug candidates for the 
treatment of neurological diseases. 
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A.2 Experimental Design - Device Layout 
Figure A.1e shows a finalized prototype consisting of a VNEA chip (25 × 25 mm) and a 
PDMS washer (12 × 25 mm). The washer contains three cell-culture wells: a double well 
centered on the electrode array (formed from two 3mm-diameter biopsy punches) for neuronal 
measurements and two additional side wells (made with a 6 mm-diameter biopsy punch) for 
culturing neurons that will condition the media. All three wells share the same culture media. 
The double-well design allows micropipettes to approach cells from the top of the device without 
hitting the sidewalls of the PDMS well. The electrode tracks, also visible in the device image and 
schematic (Fig. A.1a-e), provide electrical connection from the stimulation/recording pads to the 
metal contact pads at the base of the device. Electrical isolation between individual electrode 
pads is achieved by etching through the device layer of a SOI wafer, thus exposing the buried 
oxide (BOx). We have previously described the fabrication process in detail127. The numbers on 
the electrode pads represent the location of the corresponding metal contact pads counted from 
left to right (Fig. A.1b). In addition to the 16 metal contact pads connected to the 
stimulation/recording pads, three extra contacts (two substrate pads and one floating pad, Fig.1a) 
are used to test the electrical contact between the device and a custom printed circuit board 
(PCB) (see Mounting the Device). An important design consideration was the minimization of 
the parasitic capacitance. To this end, we designed narrow electrode tracks to reduce their 
surface area (width: 3 µm) and insulated them with a thick aluminum oxide layer (150 nm, 
shown in dark blue in Fig. A.1d) using atomic layer deposition. 
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A.3 Modes of operation 
Faradaic Recording Mode 
 Faradaic coupling refers to an ionic current flowing to or from the VNE as the result of 
electrochemical reactions at the metalized nanowire tips. This is accomplished by applying a 
voltage to the VNE with respect to a reference electrode (Ag/AgCl) in the bath solution. In our 
experimental setup (Fig. A.2 a-b), we use a custom-built current-clamp module (IC module) that 
can source up to ±10 nA with a compliance voltage of ±5V (Fig. A.2c). The Faradaic mode is 
equivalent to a patch pipette operating in current-clamp mode160: changes in the membrane 
potential are tracked by monitoring the VNE potential required to maintain a specified command 
current. In this mode, the VNE access resistance (the nanowire intrinsic resistance plus the 
electrochemical junction resistance and any residual cell membrane resistance at the nanowire-
cell interface, designated as Ra,NW in Fig. A.3c), in combination with the parasitic capacitance118 
to ground (Cp in Fig. A.3c), acts as low-pass RC filter for the recorded membrane potential. This 
RC filtering, combined with voltage division by the ratio of the leak resistance (RL in Fig. A.3c) 
to the access resistance, results in temporally broadened and attenuated signals127. Typical 
attenuation factors and RC time constants are 3-5 fold and 5-50 ms, respectively. Nevertheless, 
the original waveform can be reconstructed by deconvolving the recorded signal with the VNE 
impulse response function (measured at the conclusion of the experiment – see RC time constant 
analysis). Recordings in the Faradaic regime are usually limited to ~10 min due to degradation of 
the cellular membrane by sustained electrochemical reactions at the VNE. 
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Figure A.2 | Equipment and Software Setup. a, Schematic of the hardware setup consisting of 
a VNEA device mounted on an aluminum enclosure and positioned under an upright microscope. 
The VNEA is connected to the current-clamp (IC) module, which connects to the data 
acquisition (DAQ) module through the control electronics. The IC module and the patch-clamp 
head stage share the same Ag/AgCl reference electrode submerged in the neuronal culture bath 
solution. Patch-clamp amplifiers connected to the head stage enable conventional whole-cell 
patch clamping, and a digital camera allows imaging of the neuronal culture. A desktop 
computer connected to the DAQ module, patch-clamp amplifiers, and camera controls the 
hardware and data acquisition. b, Image of a typical setup mounted on an air table. c, Circuit 
diagram of the IC module that can source up to ±10 nA with a compliance voltage of ±5V.  
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Access Resistance and Capacitance Characterization.  
We have previously described in detail the equivalent circuit analysis of the VNE-cell 
interface (Fig. A.3 a-c)127. Characterization of the VNE electrical interface allows reconstruction 
of the original neuronal action potentials from the RC-filtered signals recorded in the Faradaic 
mode. Due to slight variations in the geometry of the nanowire electrodes, each VNE should be 
characterized individually at the conclusion of an experiment. To measure the RC time constant, 
the cells on top of the VNE should be removed either using a glass micropipette or by lysing the 
cell through the application of a large (~1nA) sustained electrochemical current from the VNE. 
Once the cell is removed, the bare-electrode RC time constant can be directly extracted by fitting 
a single exponential to the voltage response to a command current pulse (200 pA, 300 ms in 
duration). Typical time constants vary between 5 and 50 ms. Since the Faradaic current is a 
nonlinear function of voltage, the RC time constant depends on the holding current. Therefore, 
the current pulse used to characterize the RC time constant should be similar to the holding 
current used during the experiment. The approximate VNE access resistance (Ra,NW) can then be 
determined by applying Ohm’s law to the steady state voltage response to the current pulse. 
Additionally, the parasitic capacitance to ground (Cp) can be calculated by dividing the measured 
time constant by the VNE access resistance (Ra,NW). The typical parasitic capacitance (Cp) of a 
VNE is ~150 pF. To recover an unfiltered waveform from the VNE measurement, one can 
deconvolve the measured signals with the impulse response of a low pass filter possessing the 
measured RC time constant. 
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Figure A.3 | Access resistance and capacitance characterization in HEK293 cells as a model 
system a, Current injected through the nanowires (INW) results in a change in the membrane 
potential as measured at the patch pipette (Vp), confirming nanowire-based control over the 
membrane potential. Voltage changes measured at the pipette (Vp) were ~10 times smaller than 
those measured at the nanowire (VNW) due to current leakage at uncoupled nanowires or defects 
in the electrode insulation. b, Current injected through the pipette (Ip) versus time in the 
capacitive and Faradaic modes (top row, left and right columns, respectively), and the resulting 
voltage response of the cell recorded with a patch pipette (Vp, middle row) and nanowires on a 
VNE pad  (VNW, bottom row). c, Equivalent-circuit model of the VNE/cell interface. Ra,NW, 
Rs,NW, Ra,p and Rs,p represent the access and seal resistances for the nanowires and pipettes 
respectively. The capacitance of the electrical double layer at the nanowire surface is represented 
as CNW. The equivalent circuit also includes the leak resistance due to uncoupled nanowires or 
defects in the electrode insulation (RL) and the parasitic capacitance to ground due to the device 
and associated electronics (Cp). The cell itself has a characteristic membrane resistance (Rm), 
capacitance (Cm) and resting potential (Vrest), all of which combine to determine the potential 
across the cell membrane (Vm). The values of these circuit elements were determined based on 
simultaneous patch pipette and VNEA measurements such as those shown in a and b. 
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Capacitive Recording Mode 
In the capacitive mode, the electrical double layer at each metal-coated nanowire’s tip 
serves as a capacitor118 that follows fast changes in the membrane potential. Specifically, the 
charging/discharging of this double layer leads to a change in the VNE voltage that can be 
amplified via AC coupled amplifiers. The voltages measured at the VNE (Fig. A.3b) are 
typically 300 times smaller than those measured with a patch pipette due to a capacitive voltage 
division by the ratio of the total nanowire double-layer capacitance (CNW in Fig. A.3c, ~0.5 pF in 
our prototype device) to the parasitic capacitance to ground (Cp, ~150 pF). Often an initial 
voltage pulse of ±3 V for 100 ms is required to establish an intracellular recording in the 
capacitive mode, and, at times, a brief re-permeabilization pulse is necessary to re-establish 
intracellular access if the signal amplitude decreases due to the recovery of the cellular 
membrane. Recording times in the capacitive regime can last up to several hours, mainly limited 
by cell viability in ambient conditions or the effect of a patch pipette, if the cell is simultaneously 
patched. 
Analysis of Stimulation Coupling Modes   
Stimulation coupling, similarly to recording coupling, can be achieved via two distinct 
coupling modes: Faradaic and capacitive. Figure A.4 summarizes the characterization of the two 
coupling modes simulated and measured pre- and post-synaptic activity. As depicted in the 
schematic of the experimental setup (Fig. A.4a), the presynaptic stimulus was applied via the 
VNE while a patch pipette was used to monitor the activity of the postsynaptic neuron. 
Representative input (I) and output (O) traces of the presynaptic VNE voltage pulse and the post-
synaptic voltage response, respectively, are shown in Fig. A.4b. We simulated the presynaptic 
activity to thoroughly analyze the two distinct (faradaic and capacitive) VNE stimulation-
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coupling modes. Fig. A.4c – d show the simulated plots of the Faradaic current plots the 
displacement (capacitive) current, respectively, injected through the VNE in response to a 
voltage pulse (insets) of varying duration. In faradaic coupling mode, the onset of all three action 
potentials coincides, independent of the pulse duration (Fig. A.4e). In contrast, the onset of the 
action potentials stimulated via capacitive currents is directly dependent on the duration of the 
voltage pulse and follows the injection of positive current (Fig. A.4f). As expected from these 
simulations results, measured postsynaptic activity in rat cortical neurons exhibited two distinct 
coupling modes, faradaic and capacitive. In faradaic coupling mode, voltage pulses of varying 
duration (10, 20, 30, and 50ms) result in excitatory postsynaptic potentials of the same 20ms 
latency (Fig. A.4g). Similarly, excitatory postsynaptic potentials stimulated via capacitive 
coupling show a discrete distribution of latencies corresponding to the different pulse durations, 
as expected (Fig. A.4h).  
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Figure A.4 | Stimulation coupling modes. a, Schematic of the experimental setup. Presynaptic 
stimulus (I: input) was applied via the VNE while a patch pipette was used to monitor the  
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Figure A.4 (Continued). activity of the postsynaptic neuron (O: output). b, Representative input 
(I) and output (O) traces of the presynaptic VNE voltage pulse and the post-synaptic voltage 
response, respectively. τ represents the pulse duration, while Δt represents the latency between 
the onset of the stimulus and the rising edge of the post-synaptic response. c-f, Simulated 
presynaptic activity show two distinct (faradaic and capacitive) VNE stimulation coupling 
modes. c, Faradaic current injected through the VNE in response to a voltage pulse (inset) of 
varying duration. d, Displacement (capacitive) current injected through the VNE in response to a 
voltage pulse (inset) of varying duration. Note that positive current is injected at the dropping 
edge of the voltage pulse. e, Membrane response to faradaic current stimulations of varying 
durations. The onset of all three action potentials coincides, independent of the pulse duration. f, 
In contrast, the onset of the action potentials stimulated via capacitive currents is directly 
dependent on the duration of the voltage pulse and follows the injection of positive current. g&h, 
As expected from the simulations results, measured postsynaptic activity exhibits two distinct 
coupling modes, faradaic and capacitive. g, In faradaic coupling mode, voltage pulses of varying 
duration (10, 20, 30, and 50ms) result in excitatory postsynaptic potentials of the same 20ms 
latency. h, Similarly, excitatory postsynaptic potentials stimulated via capacitive coupling show 
a discrete distribution of latencies corresponding to the different pulse durations, as expected.  
 
 
 
A.4 Methods 
Cell Culture and Imaging 
Cells and cell culture media were contained within polydimethylsiloxane wells bonded to 
the VNEA surface. Dissociated E18 rat cortical neurons (BrainBits LLC) were cultured on top of 
VNEAs as previously described89. A three-well polydimethylsiloxane (PDMS) washer structure 
was used: a central double well (diameter: 3 mm, each) was employed to retain a droplet of cells 
above the VNEA during the initial 45 minutes needed for cell settling22. Two additional wells 
(diameter: 5 mm) were also seeded with cells so as to help support neuronal viability by 
conditioning the media within the larger washer structure125 (Fig. A.1e). Prior to the addition of 
cells, exposed device surfaces were coated with poly-L-lysine (typically 2 – 5 nm in thickness) to 
promote cell adhesion and growth. Epifluorescence and DIC images of live cells were overlaid 
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and colored using ImageJ. False coloring of SEM images was performed using Photoshop CS3 
(Adobe). 
 
Membrane permeabilization and visualization 
Typically, the membrane potential, as measured using a patch pipette, responded 
immediately to the application of current via the VNEA pad (-200 to -400 pA), suggesting that 
some of the nanowires formed a tight seal with the cell membrane and penetrated the cells on 
top. In the absence of immediate electrical coupling, permeabilization could be achieved by 
applying 100 ms voltage pulses with amplitudes of ~ ±3 V. Membrane permeabilization was 
typically accompanied by a depolarization of Vm by 10 ~ 20 mV; lowering the holding current on 
the recording pad or the patch pipette reversed this depolarization. Confocal microscopy imaging 
of cortical neurons cultured on vertical silicon nanowires (3 days in vitro (DIV)) showed that 
some neurons appeared penetrated by nanowires while others did not, consistent with our 
electrical measurements (Fig. 3.3). Images were obtained by labeling the nanowires with 
Alexa647-SE in DMSO (1mg/mL, Invitrogen)89. After a 30-minute incubation at 37oC, samples 
were washed three times through water, blown dry, and used as a substrate for neuron culture. 
Prior to imaging, neuronal membranes were labeled by incubating the samples in extracellular 
solution containing 1:100 Vybrant DiI (Invitrogen) at room temperature. Images were then 
analyzed and reconstructed in 3D using Imaris 6.2 (Bitplane). 
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Patch Pipette Recording  
During measurements, VNEA substrates were bathed in a solution containing [in mM]: 
NaCl [119], KCl [5], HEPES [20], CaCl2 [2], MgCl2 [2], glucose [30], and glycine [0.001]. The 
pH of the solution was 7.3 and the osmolarity was 330 mosM (adjusted with sucrose). Patch 
pipettes were pulled to have resistances of 2 ~ 10 MΩ and then backfilled with a solution 
containing [in mM]: potassium gluconate [130], KCl [10], MgCl2 [5], EGTA [0.6], HEPES [5], 
CaCl2 [0.06], Mg-ATP [2], GTP [0.2], leupeptine [0.2], phosphocreatine [20], and creatine 
phosphokinase [50 U/ml] with the pH at 7.2126. For certain experiments, high-purity calcein 
(Invitrogen) was added (1 part in 5000) into the intracellular recording solution to enable 
fluorescence imaging of the patched cell. All recordings were made at room temperature with a 
Multiclamp 700B (Molecular Devices). Current-clamp recordings of HEK293 cells were 
performed with a holding current of 0 pA. During neuronal measurements, the holding current 
was adjusted to bring the neuron to a resting membrane potential near -70 mV for stimulation 
and recording experiments, and -40 mV for PSP identification. The pipette capacitance was 
corrected electronically. All acquisitions were performed using the pCLAMP 10 software 
(Molecular Devices) and analyzed and plotted using Clampfit 10 (Molecular Devices) and 
Matlab (Mathworks). 
 
Protocols for VNEA stimulation and recording 
For VNEA stimulation and recording experiments, the devices were mounted in a 
custom-built aluminum enclosure designed to provide both electrical connection to the VNEA 
pads and electromagnetic shielding. The connection between the VNEA and 
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stimulation/measurement electronics was achieved using conductive elastomeric connectors 
(ZEBRA, Fuji-poly) and a custom-built printed circuit board. 
 Neuronal stimulation was achieved using a 32-channel analog output module 
(National Instruments PXI-6723) and control software written in LabView (National 
Instruments). During VNEA stimulation, capacitive electronic cross-talk between the patch 
pipette and VNEA was removed by subtracting the characteristic transients. Current-clamp 
measurements were performed using a custom-built current-clamp circuit with stability on the 
order of 10 pA and compliance values between +/-10 V and +/- 5nA. Currents were controlled 
using our analog output module, and recorded voltages were amplified using AM Systems Model 
1800 (gain: 100×, bandwidth: 1 Hz - 20 kHz). Both pre- and post-amplified voltages were 
collected and digitized. Capacitively-coupled measurements were recorded directly with the AM 
Systems amplifier, and digitally filtered to remove 120Hz line noise. To preserve the 
simultaneity of the pipette and VNEA measurements, all signals were recorded and digitized 
simultaneously using the pCLAMP 10 software and a 16-channel analog data acquisition system 
(Axon Digidata 1322A, Molecular Devices). 
Steady-state control of the membrane potential (as measured by the patch pipette (Vp)) 
could be achieved for several seconds by changing the offset voltage applied to the nanowires 
(VNW) (Fig. 3.5). 
 
PSP identification 
To identify excitatory (EPSPs) and inhibitory PSPs (IPSPs), we patched a rat cortical neuron (14 
DIV) in whole-cell current-clamp mode. Several representative EPSPs/IPSPs were manually 
identified and averaged to form a template (Fig. A.3b). Once a template was obtained, automatic 
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event detection was performed using Clampfit 10. Latencies were calculated as the interval 
between the rising edge of the stimulus and the peak of the PSP. Data was then compiled and 
plotted using Matlab. 
 
 
A.5 Initial Results of High-throughput Study of Synapses and Network Dynamics In Vitro 
The VNEA device enables parallel stimulation and measurement of mammalian neuronal 
activity. Voltage pulses applied to the VNE with respect to the reference electrode result in 
current being injected intracellularly, which in turn reliably excites action potentials (Fig. A.5a). 
Simultaneous whole-cell patch-clamp measurements show that the stimulation probability 
depends sigmoidally on the magnitude of the current injected through the nanowires (Fig. A.5b). 
Furthermore, in the current-clamp mode, the VNEA reliably records single-shot action potentials 
with a signal-to-noise ratio of 100:1 (Fig. A.5c). This signal-to-noise ratio can be improved to 
>1000:1 by averaging multiple waveforms obtained under identical experimental conditions. 
Having demonstrated these capabilities, we utilized our VNEA to modulate in vitro neuronal 
circuits (Fig. A.5d – g). In particular, we implemented paired VNE-patch pipette stimulations to 
modify synaptic strengths according to spike-timing-dependent plasticity rules. Briefly, 
stimulation of a presynaptic neuron on top of the VNE (cell A) results in an excitatory 
postsynaptic potential (PSP) in cell B as recorded using a patch pipette in a whole cell 
configuration (Fig. A.5d). To depress the synaptic strength, an action potential was evoked in 
cell B 40ms prior to VNE stimulation (Fig. A.5e, (i)). This paired stimulation was repeated 40 
times every 1 s.  To potentiate the synapse an action potential was evoked 40 ms after VNE 
stimulation and repeated as in the prior training protocol (Fig. A.5e, (i)). As expected from spike-
timing-dependent plasticity rules, the synaptic strength, or average EPSP amplitude, decreases 
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following protocol (i – red) and recovers following protocol (ii – blue). In addition, bar chart of 
the average normalized EPSP amplitude show a 20% depression followed by 20% potentiation in 
response to the training protocols i and ii, respectively.  
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Figure A.5 High-throughput study of synapses and network dynamics in vitro a, Action 
potentials were reliably stimulated by voltage pulses applied to a VNE (magenta) and  
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Figure A.5 (Continued). recorded using a patch pipette (blue). b, Probability of action 
potential (AP) excitation plotted as a function of current injected by nanowires shows a 
sigmoidal dependence (dashed line), which is similar to AP excitation elicited by 
intracellular patch pipettes. Probabilities were calculated for 20 trials and plotted as a 
function of the stimulation current. Error bars represent 95% confidence intervals. Inset: five 
consecutive time-aligned action potentials stimulated by nanowire current injection show less 
than 1 ms jitter.  c, The VNE can also measure action potentials (magenta) that were 
stimulated using a patch pipette (blue) . VNEA measurements show good agreement with 
those obtained simultaneously by a patch pipette. d-g, Paired VNE-patch pipette stimulation 
modify synaptic strengths according to spike-timing-dependent plasticity rules. d, Composite 
bright-field and fluorescence image of a cortical neuron patched and backfilled with calcein 
(13 DIV). e, Stimulation of a presynaptic neuron on top of the VNE (cell A) results in an 
excitatory postsynaptic potential (PSP) in cell B as recorded using a patch pipette in a whole 
cell configuration. To depress the synaptic strength, an action potential was evoked in cell B 
40ms prior to VNE stimulation (i). This paired stimulation was repeated 40 times every 1 s.  
To potentiate the synapse an action potential was evoked 40 ms after VNE stimulation and 
repeated as in the prior training protocol (ii) f, As expected from spike-timing-dependent 
plasticity rules, the synaptic strength, or average EPSP amplitude (horizontal dashed lines), 
decreases following protocol (i  - red) and recovers following protocol (ii - blue). g, Bar chart 
of the average normalized EPSP amplitude showing a 20% depression followed by 20% 
potentiation in response to the training protocols i and ii, respectively.  
 
 
 
A.6 MATERIALS 
REAGENTS 
• E18 hippocampus and cortex without the subventricular region (BrainBits, cat. 
no. HPCtx) 
• Dental wax (Gumbrand, cat. no. 724RQD)  
• TrypLE Express (Gibco, cat. no. 12604) 
• 100% Ethanol (VWR) 
• Refer Table 1 for media reagents 
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EQUIPMENT 
• VNEA device with PDMS well 
• Zebra Elastomeric Connector (Fujipoly, cat. no. S5002 8Z100) 
• Custom-made PCB 
• Custom-made aluminum enclosure 
• Custom-made IC module 
• Reference electrode, Ag/AgCl pellets (Warner Instruments, cat. no .64-1309)  
• Connector pins (Warner Instruments, cat. no. 64-1326) 
• Various cables, including rainbow and BNC cables (Warner Instruments) 
• Shielded Connector Block, (BNC 2100, National Instruments, cat. no. 777643-01) 
• Amplifier (AM systems, model 1800 2-channel microelectrode AC amplifier, cat. 
no. 700000) 
• Data acquisition system (Axon Instruments/Molecular Devices, Digidata 1322A, 
with pCLAMP 10 software) 
• DC power supply (Agilent Technologies, cat. no. E3617A) 
• Upright microscope with water immersion objective (Olympus BX61WI, 
UMPlanFi 20×/0.5)  
• Air table (Newport) 
• Digital microscope camera (QImaging) 
• Digital Voltmeter (Fluke, cat. no. IV-77-4)  
• Control software (LabView) 
• Desktop computer 
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NEURON CULTURE 
Neuronal culture 
• Plasma cleaner (Harrick Plasma, cat. no. PDC-32G) 
• Convection oven (Yamato DX300) 
• Shaker (VWR, cat. no. 89032-088) 
• Water bath (VWR, cat. no. 97025-110) 
• Alconox liquid detergent (VWR, cat. no. 89092-536) 
• Laminar flow hood (Nuaire) 
• Cell culture incubator (Thermo Scientific, cat. no. 3307-MAR) 
• Bunsen burner (VWR, cat. no. 89038-530) 
• Glass pipettes (VWR, cat. no. 53499-630) 
• Extended length plastic pipette tips (Rainin cat. no. RT-l250XS) 
• Scalpel (BD Bard-Parker no. 23 or 24, cat. no. 371223) 
• 1.5 ml Microcentrifuge tubes (Eppendorf, cat. no. 022364111) 
• 60 mm Petri dish (BD, cat. no. 354401) 
• 15 mL conical-bottom centrifuge tube (BD cat. no. 352097) 
• 10 mL syringe (BD cat. no. 309604) 
• Spec-Wipe wipers (VWR cat. no. 21914-758) 
• Acrodisc syringe filter (Pall Life Sciences cat. no. PN 4192) 
• Hemocytometer (iN CYTO cat. no. DHC-N01-5) 
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PATCH CLAMPING (OPTIONAL) 
• Micropipette puller (Sutter P series Flaming/Brown pipette puller; Sutter 
Instruments Model P-97) 
• Borosilicate pipettes (Warner Instruments, 64-0790) 
• Micromanipulators (Sutter Instruments, ROE-200) 
• Current- and voltage-clamp head stage (Axon Instruments, CV-7B) 
• Current- and voltage-clamp module (Axon Instruments, Multiclamp 700B) 
• Data acquisition system (Axon Instruments/Molecular Devices, Digidata 1322A, 
with pCLAMP 10 software) 
• Tygon tubing (US Plastics, cat. no. 57102)) 
• Connectors for tubing (Harvard Apparatus, cat. no. 721410) 
• 1 mL syringes (VWR, cat. no. 53548-001) 
 
A.7 PROCEDURE 
Steps 1-5: Preparation of a VNEA device 
1. To prepare a VNEA device for neuronal culture, clean the device in oxygen 
plasma (10 min, 50 W, 40 sccm O2). 
2. Sterilize the device in 100% ethanol for 30 minutes (min) and transfer it to the 
laminar flow hood. Note: All procedures from this step on are to be conducted under 
sterile conditions. 
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3. Rinse the VNEA device three times in double-distilled water (dd-water) and 
transfer it to a sterile 60-mm petri dish. Using a plastic pipette tip, carefully aspirate any 
remaining water. Allow the device to dry completely (~10 min). 
4. Carefully add 300 µL of mixed poly-L-lysine solution to the PDMS wells, or as 
much as is needed to fill the wells without spilling over. Cover the dishes and incubate 
the device for two hours. 
Critical step: The poly-L-lysine solution must not dry out during incubation. 
5. Using a plastic pipette tip, aspirate the poly-L-lysine from the VNEA device. 
Rinse the PDMS well with dd-water, aspirate, and allow it to dry. 
Critical step: Steps 1-3 can be completed a day before neuron plating. However, the 
poly-L-lysine treatment should be done on the same day as the neuronal culture. 
 
Steps 6-17: Neuron dissociation, plating, and culture119,165-167 
6. Half an hour prior to neuron dissociation and plating, pre-warm Culture Media + 
Glu to 37°C in a water bath (8 mL per VNEA device, plus 5-10 mL for the culture). Also, 
pre-warm a 50 mL aliquot of 9:1 Media. 
7. Neurons used for plating are E18 rat combined hippocampal and cortical neurons 
(BrainBits, LLC). Store the neurons at 4°C until ready to use. Transfer the vial of neurons 
to the laminar flow hood, along with 50 mL cold Modified HBSS Solution, divided into 
10 mL and 40 mL aliquots. 
8. To the 10 mL aliquot of Modified HBSS Solution, add 100 µL of 100x Enzyme 
Solution, 200 units of papain, and 100 µL of DNAse I. Mix thoroughly and filter-
sterilize. Set aside. 
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9. Carefully remove the media containing neurons from the vial and transfer to the 
lid of a 60-mL petri dish. If there are any large pieces, cut with a scalpel. Transfer the 
neurons to a 14-mL Falcon tube, add ~13 mL of Modified HBSS Solution (without 
enzymes), and allow neurons to settle to the bottom (1-2 min). Aspirate most of the 
media out of the Falcon tube and rinse the neurons with ~13 mL of Modified HBSS 
Solution (without enzymes). Repeat the settling and rinsing once more. 
10. Aspirate the Modified HBSS Solution from the Falcon tube one final time and 
add the 10 mL aliquot of Modified HBSS Solution mixed with enzymes. Transfer the 14-
mL tube containing the neurons to a tissue culture incubator set to 37 C and 5% CO2. 
Loosen the cap of the Falcon tube to allow equilibration. Incubate for 30 min. Critical 
step: The incubation should not exceed 30 min. During the 30-min incubation, also 
transfer the pre-warmed Culture Media + Glu and 9:1 Media to the tissue culture 
incubator. Loosen the caps to allow equilibration. 
11. Following the 30-min incubation, bring the Falcon tube containing neurons and 
the tubes of equilibrated Culture Media + Glu and 9:1 Media into the laminar flow hood. 
Carefully aspirate the media from the Falcon tube and rinse it with 9:1 Media. Allow the 
neurons to settle and repeat the rinse twice more. 
12. Aspirate as much media as possible from the Falcon tube and re-suspend the 
neurons in 1 mL Culture Media + Glu. Using a small diameter pipette tip, gently pipette 
up and down six to ten times to re-suspend the neurons (until the neurons appear to be 
evenly dispersed). Critical Step: Do not over-pipette. This will result in reduced cell 
viability. 
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13. Using a hemacytometer, count the neurons and dilute the cell suspension to a 
concentration of 1 x 106 cells/mL. Plate 2.5 x 105 neurons per VNEA device. Incubate the 
device at 37°C for 30 min, allowing the neurons to settle on the surface. Return the 
Culture Media + Glu to the incubator for this time as well, leaving the cap loose. 
14. After the 30-min incubation, very slowly and carefully, add 8 mL Culture Media 
+ Glu to a 60-mm petri dish containing the VNEA device. The entire device should be 
submerged. 
15. Culture the petri dish that contains the VNEA device with plated neurons for 6-14 
days (until ready to record) at 37°C and 5% CO2 to allow neuron maturation and 
synaptogenesis.  
16. The day after plating, change out 30% of the media from the petri dish. 
17. Continue to perform a 30% media swap every 3-4 days. After 7 days in vitro 
(DIV), start to use Culture Media - Glu. 
 
Steps 18-29: Mounting the device (Fig. A.6) 
18. Check neuron viability in an upright microscope to ensure that the neurons on the 
VNEA are healthy and that cells are resting on top of the electrodes.  
19. Identify and note the pads with neurons residing on top of them (e.g., Fig. A.6b). 
20. Carefully remove the device from the media dish and place it on a Spec-Wipe 
wiper. Critical step: The PDMS culture well should not dry out at any point. 
21. Spray a clean wipe with dd-water and wipe the metal contact pads at the bottom 
of the VNEA device from top to bottom to remove any residual salt. Repeat as needed to 
achieve a clean surface. Critical step: Complete removal of salt residue is important to 
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prevent electrical shorting of the metal contact pads when they are connected to the 
control electronics. 
22. Spray another wipe with 70% ethanol and further clean the metal contact pads by 
wiping top to bottom. Critical step: Be careful not to make contact to the media well 
with the alcohol wipe. 
23. Mount the device in the holder. Align the metal contact pads to the PCB contacts, 
press the VNEA device flush to the PCB and clamp it in place. Critical step: Make sure 
the height of the VNEA chip matches the PCB. Height mismatches can lead to over- or 
under-compression of the zebra rubber and poor electrical contact. Pieces of scotch tape 
can be used to shim the VNEA chip to match the PCB height (Fig. A.6b). 
24. Carefully position the zebra rubber on top of the device and PCB contacts (Fig. 
A.6c). Tighten the zebra rubber screws finger tight and use a digital multimeter (DMM) 
to measure the resistance between the two device layer contacts (S1 and S2) by probing 
the corresponding connectors at the bottom of the PCB (Fig. A.6c). Resistance should 
read ~100 kΩ. Then check the resistance between each VNE (metal contact pads 1 
through 16) and the device layer (metal contact pads S1 or S2). The resistance between 
the contact pads and device layer should be large enough to overload the DMM (typically 
>50 MΩ). If the resistance between the VNE and the device layer is <50 MΩ it will not 
be possible to record signals using this electrode. Critical step: Zebra rubber is designed 
to operate at 5-25% compression. Over- or under-compression can lead to poor electrical 
contact. See Troubleshooting 
25. Place a reference electrode in the PDMS well and secure it using dental wax. 
Make sure it is connected to the return port of the custom-made IC module. 
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26. Connect the I-out port from the IC module to the connector on the PCB that 
corresponds to a bare VNE (without neurons on top). This will be used to check proper 
electrical contact (be sure to select a VNE that you do not intend to use for an 
experiment).  
27. Place the aluminum enclosure over the PCB and fasten with screws. 
28. Optional: Carefully slide the enclosure under the microscope. 
29. Double check that the electrical connections are still in place after moving the 
enclosure. 
 
Figure A.6 | Mounting of the device. a, Top view of the aluminum enclosure base 
containing a printed circuit board (PCB) with one pad connected to the IC module. b, A VNEA 
	  113	  
	  
Figure A.6 (Continued). device mounted on the aluminum enclosure base with contact pads 
aligned to the contacts on the PCB and held in place by an aluminum clip. c, Zebra rubber (under 
the metal clamp) screwed in place to connect the device contact pads to the PCB pads. d, 
Aluminum enclosure top covering the PCB provides electromagnetic shielding. e, Side view of 
the aluminum enclosure with a VNEA positioned under an upright microscope (top). A reference 
electrode placed in the bath solution connects to both the IC module (right) and the patch-clamp 
head stage (left).  
 
Steps 30-36: RC Time constant characterization 
30. Measure the voltage-dependent RC time constant of a VNE that is not intended 
for neuronal measurement. This measurement is to confirm good electrical contact 
between the PCB and VNEA. 
31. Using a voltage source, command the custom-made IC module to apply a 600 pA 
pulse through the VNE for 300 ms. 
32. Increase or decrease the offset current by 200 pA. Wait 2-3 seconds for the 
electrode to stabilize, and stimulate again. 
33. Repeat step 32 until holding at  ±6 nA.  
34. If traces show large voltage fluctuations (> 20 mV), repeat steps 31-33 to 
condition the VNE. 
35. Due to the non-linear I-V relationship of electrochemical reactions at the 
nanowire tip, the VNE access resistance should decrease as the absolute value of the 
offset current increases. Thus, the voltage needed to drive the 1.5-nA current pulse (as 
well as the RC time constant) should decrease as the magnitude of the holding current 
increases (see Fig. A.6c). If the recorded waveforms do not follow this trend, try to 
record from another VNE. If the traces still do not show the expected trend, there is likely 
an electrical short, and you should fix this problem (Step 24). 
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36. Note: The same procedure can be used at the end of the experiment to extract the 
RC time constant of the individual electrode pads, as detailed in the introduction.  
 
Steps 37-40: Stimulation via current injection with the VNE 
37. Optional: Patch the neuron of interest in whole-cell mode for simultaneous 
measurement60,160,161.  
38. Permeabilize the cellular membrane to ensure nanowire intracellular access. This 
procedure can be performed by injecting a short current pulse through the nanowires 
(duration: 100 ms, magnitude: ± 1 nA to 3 nA). A brief drop in the membrane resistance 
will accompany this permeabilization procedure but will typically recover to the original 
value within a few seconds. 
39. Stimulate the neuron by injecting a current pulse through the nanowires. Current 
pulses 10 ms in duration and 200-400 pA in magnitude can reliably excite action 
potentials (Fig. A.6d). Lower magnitude pulses can be used to shift the membrane 
potential without eliciting an action potential. Repeat as needed. 
40. Optional: Monitor the neuron’s response via the patch pipette. When this 
procedure is used, the experimental duration will be limited to the time that a stable patch 
clamp can be maintained. See Troubleshooting 
41. Optional: To stimulate at multiple pads during a single experiment, use a ribbon 
connector to connect all of the outputs on the PCB directly to the analog out channels of a 
16-channel data acquisition (DAQ) module. 
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Steps 41-43: Measurement of neuronal activity in the Faradaic mode 
42. Alternatively, utilize the VNE to monitor the neuronal activity in current-clamp 
mode. 
43. Set the VNE holding current to ±750pA. Lower/raise this holding current in 
increments of 100pA until the VNE begins to record a signal. Record the voltage trace 
using a data acquisition module of choice. Critical step: Lowering/raising the holding 
current reduces/increases the nonlinear VNE resistance. Special attention must be paid 
not to inject a large current into the cell (i.e. large holding current) in order to minimize 
cellular damage. Timing: The recording period in the Faradaic mode can last up to 10 
min and is limited by electrochemical reactions at the electrode interface within the cell. 
This eventually produces swelling and breakdown of the cellular membrane. 
44. At the end of the experiment, the approximate access resistance and capacitances 
of the VNE interface can be determined using steps 29-34. 
 
Steps 44-45: Measurement of neuronal activity in the capacitive mode 
45. To operate the device in the less invasive capacitive mode, connect an AC-
coupled amplifier to the PCB connectors. Critical step: Take care in performing this step 
- changing the connection to the PCB from the custom-made IC module to the AC 
amplifiers may break the seal of a patch pipette. 
46. The output of the AC-coupled amplifier can be digitized and recorded using a 
data acquisition module of choice. Recordings can last up to several hours and are 
typically limited by cell viability in ambient conditions. 
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Steps 46-52: Cleaning 
47. At the conclusion of an experiment, rinse the device by first spraying dd-water 
from a squirt bottle to physically remove the cultured neurons and rinse out the salt 
solution. Critical step: Do not allow the device to dry before washing it with dd-water 
48. Transfer the rinsed device to a petri dish and add enough TrypLE to cover the 
device. Place the petri dish on a shaker for 20 min. 
49. Rinse with dd-water. 
50. Prepare another petri dish with a soap-water solution. Transfer the device to an 
orbital shaker and shake it for 20 min. 
51. Rinse with dd-water and transfer the device to a clean petri dish with dd-water. 
Keep it on a shaker for 30 min. 
52. Blow-dry with a nitrogen gun.  
53. Store in an oven at 60°C to allow any solvents absorbed in PDMS to dry out. 
A.8 TIMING 
Steps 1-5: Preparation of VNEA devices - 4 h. 
Steps 6-17: Cell dissociation, plating, and culture - 2 h, 6 to 14 days incubation time. 
Steps 18-29: Mounting the device - 10 to 30 min. 
Steps 30-36: RC time constant characterization - 15 min. 
Steps 37-40: Stimulation via current injection - 1 to several hours. 
Steps 41-43: Measurement of neuronal activity (Faradaic mode) - 1 to 10 min. 
Steps 44-45: Measurement of neuronal activity (capacitive mode) - 1 to several hours. 
Steps 46-52: Cleaning - 1 h 30 min. 
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A.9 TROUBLESHOOTING 
Troubleshooting advice can be found in Table A.2.  
Table A.1. Media and Recording solutions 
Medium Components Final  Concentration Source 
Modified HBSS 
Solution 
10x HBSS, no 
Calcium, no 
Magnesium 
99% Life Technologies,  cat. no. 14170-112 
 1 M HEPES 10 mM Life Technologies,  cat. no. 15630-080 
 Notes: pH to 7.3 and filter-sterilize (0.2 µm). Aliquot into sterile 
50 mL tubes. Store at 4⁰C. 
9:1 Media 9 parts Modified HBSS Solution 90% 
 
 1 part FBS Qualified 
One Shot 10% 
Life Technologies,  
cat. no. 10437-077 
 Notes: Filter-sterilize (0.2 µm) and aliquot into 50 mL tubes. Store 
at 4⁰C. 
100x Enzyme 
Solution L-cysteine 20 mg/mL 
Sigma-Aldrich, cat. 
no. C7352 
 EDTA 50 mM Sigma-Aldrich, cat. no. EDS-100G 
 CaCl2 150 mM EMD Millipore, cat. no. 3000-500GM 
 Notes: Store at 4⁰C. 
Papain Papain 200 units/mL Sigma-Aldrich,  cat. no. 76218 
 Notes: Store at -20⁰C. 
DNase I Dnase I 500 units/mL Life Technologies,  cat. no. 18047-019 
 Notes: Store at -20⁰C. 
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Table A.1 
(Continued) 
 
 
Culture Media + 
Glu 
Neurobasal Medium 98% 
 
Life Technologies,  
cat. no. 21103-049 
 B-27 Serum-Free 
Supplement (50x) 2% 
Life Technologies,  
cat. no. 17504-044 
 200 mM L-Glutamine 0.5 mM Life Technologies,  cat. no. 25030-081 
 L-Glutamic acid 25 uM Sigma-Aldrich,  cat. no. 49449 
 Notes: Filter-sterilize (0.2 µm) and aliquot into 50 mL tubes. Store 
at 4⁰C. 
Culture Media - 
Glu Neurobasal Medium 98% 
Life Technologies,  
cat. no. 21103-049 
 B-27 Serum-Free 
Supplement (50x) 2% 
Life Technologies,  
cat. no. 17504-044 
 200 mM L-Glutamine 0.5 mM Life Technologies,  cat. no. 25030-081 
 Notes: Filter-sterilize (0.2 µm) and aliquot into 50 mL tubes. Store 
at 4⁰C. 
Mixed Poly-L-
Lysine Solution 
poly-L-lysine solution, 
mol. wt. 70,000-
150,000 
50% Sigma-Aldrich,  cat. no. P4707 
 
poly-L-lysine solution, 
mol. wt. 150,000-
300,000 
50% Sigma-Aldrich,  cat. no. P4832 
 Notes: Filter-sterilize (0.2 µm) and store at 4⁰C. 
Intracellular 
Recording 
Solution 
Potassium-D-
Gluconate, 99% 136.5 mM 
Alfa Aesar,  
cat. no. B25135 
 Potassium Chloride 17.5 mM Sigma-Aldrich,  cat. no. P9333 
 
Sodium chloride, 
crystalline powder 
PDV, 99+% 
9 mM Alfa Aesar,  cat. no. A12313 
 Magnesium chloride 
hexahydrate 1 mM 
Alfa Aesar,  
cat. no. 36226 
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Table A.1 
(Continued) 
 
 
HEPES 10 mM 
 
Sigma-Aldrich,  
cat. no. H3375 
 EGTA 0.2 mM Sigma-Aldrich,  cat. no. E4378 
 Notes: pH to 7.2 and filter-sterilize (0.2 µm). Aliquot into sterile 
50 mL tubes. Store at 4⁰C. 
Extracellular 
Recording 
Solution 
Sodium chloride, 
crystalline powder 
PDV, 99+% 
145 mM Alfa Aesar,  cat. no. A12313 
 Potassium Chloride 3 mM Sigma-Aldrich,  cat. no. P9333 
 HEPES 10 mM Sigma-Aldrich,  cat. no. H3375 
 Calcium chloride 
dihydrate 3 mM 
Alfa Aesar,  
cat. no. 33296 
 D-(+)-Glucose 8 mM Alfa Aesar,  cat. no. A16828 
 Magnesium chloride 
hexahydrate 2 mM 
Alfa Aesar,  
cat. no. 36226 
 Notes: pH to 7.3 and filter-sterilize (0.2 µm). Aliquot into sterile 
50 mL tubes. Store at 4⁰C. 
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Table A.2. Troubleshooting table 
Step Problem Possible reason Solution 
24 The DMM 
overloads when 
measuring the 
resistance between 
the device and the 
PCB contacts. 
• Poor 
contact between the 
zebra rubber and the 
device metal contact 
pads. 
• Tighten the zebra 
rubber and measure the 
resistance again. Repeat as 
necessary until the resistance 
reads ~100kΩ. 
24 VNE-device layer 
shorting: The 
DMM does not 
display a steady 
overload (> 50 
MΩ) when 
measuring 
between a VNE 
and the device 
layer. 
• Height 
misalignment 
between the VNEA 
and PCB or over 
compression of zebra 
rubber. 
• Media 
leaking from the 
PDMS well. 
• Salt 
residue on pads or 
zebra rubber. 
 
• Try loosening the 
zebra rubber such that you still 
have contact between the two 
substrate-pads. Double check 
that you have aligned the 
heights properly. 
• Check for leaking 
media around the base of the 
PDMS by aspirating excess 
media and drying the sample. 
Next, refill the media and check 
for the re-wetting at the base of 
the PDMS well. If sample leaks 
through the PDMS, it will need 
to be resealed before performing 
an experiment. 
• Take sample out; 
look for signs of solution on the 
zebra rubber (due to leaks that 
might have been hard to see). 
Carefully clean the contacts and 
zebra rubber again with ethanol 
and try again. 
40 Action potentials 
can’t be stimulated 
• Low 
amplitude current 
pulse 
• Increase the 
amplitude of the current pulse in 
steps of 100pA. The exact 
threshold for stimulation can 
vary between cells and 
electrodes. 
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